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Zusammenfassung
In der quantitativen Proteomforschung werden durch massenspektrometrische Ver-
fahren die vorhandenen Mengen einzelner Peptide und Proteine in unterschiedlich
behandelten Zellen miteinander verglichen. Dabei kommt es zu Messungenauigkei-
ten, welche die Ergebnisse und somit die Hypothesenbildung verfälschen können.
Davon betroffen sind hauptsächlich niedrige Signalintensitäten, bei welchen der
Anteil des Rauschens einen signifikanten Anteil der gesamten Signalintensität aus-
machen kann.
In der vorliegenden Arbeit ist es gelungen, das beobachtete Rauschen inner-
halb eines difinierten Analyseablaufes mit Hilfe eines spezifischen Rauschmodelles
zu beurteilen. Das Modell ermöglicht eine der Glaubwürdigkeit entsprechende
Berechnung einzelner Peptidregulationsfaktoren sowie eine gewichtete Berechnung
von Regulationsfaktoren für eine Gruppe von Peptiden, z.B. alle Peptide eines
Proteins. Die so abgeleitete regulatorische Information wird durch Likelihoodkur-
ven visualisiert, welche die Likelihood für den wahrscheinlichsten sowie alternative
Regulationsfaktoren darstellen. Anhand der Gestalt einer Likelihoodkurve kann
auf die Robustheit der zu Grunde liegenden Daten geschlossen werden.
Da die Entdeckung neuer post-translationaler Modifikationen essentiell für das
Verständnis dynamischer Proteinnetzwerke ist, sind quantitative massenspektrome-
trische Analysen auf der Peptidebene derzeit Ziel vieler biologischer Projekte.
Modifizierte Peptide sind häufig nur in sehr geringen Mengen vorhanden, daher
ist die Beurteilung der Robustheit besonders für diese Peptide von großem Inter-
esse. Wenn ein Peptid modifiziert wird, nimmt korrespondierend die Menge seiner
unmodifizierten Form ab. So kann gelegentlich beobachtet werden, dass diese im
Massenspektrum neben dem modifzierten und in eine Richtung regulierten Peptid
vorhanden und dann oft in in die Gegenrichtung reguliert ist. Da mittels Massen-
spektrometrie nur nach einer oder sehr wenigen der über 200 beschriebenen Arten
von Modifikationen gleichzeitig gesucht werden kann, ist die Detektion von dif-
ferentiell regulierten Peptiden innerhalb eines Proteins von größtem Interesse, um
so auf potentielle neue Modifikationen schließen zu können. Zu diesem Zweck ist
in der vorliegenden Arbeit neben der Berechnung der regulatorischen Information
ein Clusteringalgorithmus entwickelt worden, welcher (auf dieser basierend) nach
differentiell regulierten Peptiden eines Proteins sucht.
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Summary
In quantitative proteomics the amounts of individual peptides and proteins within
differentially treated cells are compared by mass spectrometry. Occuring impre-
ciseness of the measurements can adulterate the results and thus, formulation of
hypotheses. Especially low signal intensities are affected since considerable per-
centages of those may be caused by noise.
In this work, the observed intensity dependent noise within a defined quantitative
mass spectrometry based workflow could be modelled by the development of a
specific noise model. Both calculation of regulation factors of single peptides and
calculation of such of peptide groups (e.g. all peptides identified within one protein)
is derived from the noise model. In doing so, all calculations are weighted according
to the robustness of the underlying data. The regulatory information obtained in
this way, is visualised by likelihood curves presenting the likelihood of the most
probable as well as alternative regulation factors. The reliability of the most
suitable regulation factor – and consequently the robustness of the data – can be
inferred from the shape of the curves.
As the detection of novel post-translational modifications (PTM) is essential for
the understanding of dynamic protein networks, many biological projects currently
aim on quantitative analyses by mass spectrometry on the peptide level. Often,
the abundances of modified peptides are very low and therefore, the statistical
evaluation of the regulatory information is of highest importance regarding such
peptides. During modification of a peptide, the amount of the unmodified peptide
decreases correspondingly. Thus, in mass spectra not only the modified and op-
tionally regulated peptide but also the unmodified variant of the same peptide –
regulated contrary – can be observed. The detection of PTM by mass spectrometry
is restricted to just a few out of more than 200 different kinds of modifications at
the same time. Consequently, the identification of differentially regulated peptides
within the same protein is highly interesting for the investigation of new peptide
modifications. For this purpose, besides calculation of regulatory information a
clustering algorithm was developed in this work that is able to find differentially
regulated peptides of a protein.
2
1 Introduction
Increasing amounts of data generated by today’s high-throughput technologies re-
quire enhanced strategies for the interpretation and handling of data. Besides
optimised strategies for data storage e.g. by databases and data warehouses con-
cepts from machine learning and data mining are introduced into analysis of high-
throughput data, e.g. genomics, transcriptomics, metabolomics and proteomics.
The dominant ‘omics’ field during the last decade was genomics, which addresses
the genome sequence including the genes, their structure and encoded functional
information. Meanwhile, over 700 bacterial and 22 eukaryotic genomes includ-
ing the human genome comprising 3.000.000.000 basepairs (bp) were completed 1.
Transcriptomics studies the set of all messenger RNA molecules (“transcripts”) of
one population of cells. Hundreds or thousands of genes are analysed regarding
their expression often using high-throughput techniques based on DNA microarray
technology. The metabolome represents the set of all metabolites – intermediates
and products of metabolism – in an organism. Thus, metabolomics is the quan-
titative analysis of metabolites often using approaches from mass spectrometry
which is one of the main techniques in proteomics as well. Proteomics aims at
the identification and representative characterisation of all proteins in a cell un-
der defined conditions (proteome). Like the transcriptome and the metabolome,
the proteome is highly dynamic and varies significantly regarding its qualitative
and quantitative composition during the cell cycle and changing environmental
conditions.
Objectives of this Work Proteins and their fragments (peptides) are anal-
ysed quantitatively by application of a mass spectrometry approach (LC-MS/MS)
joined with one of the available labelling techniques (e.g. iTRAQTM ). Simi-
lar to most measurements, quantitative analysis of peptides and proteins using
iTRAQTM is corrupted by noise. Usually, those imprecision does not influence a
high signal significantly. Low intensities, however, can be highly affected by such
additional intensities. As a possible consequence the observed regulation factor
does not correlate with the real relative abundances of the investigated objects
1http://www.ncbi.nlm.nih.gov/genomes/static/gpstat.html, 17.10.08
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or, as an extreme example, the information suggests even an opposite and wrong
direction of regulation.
Regarding signal transduction studies and post-translational modifications the
amounts of available peptides often are very small and therefore, small intensities
are highly important for the detection of regulations and post-translational mod-
ifications. Thus, small intensities that are potentially strongly affected by noise,
can not be discarded and consequently, the evaluation of their reliability is re-
quested. An approach for the analysis of the robustness of those data is to apply
a noise model reflecting the likelihood of the calculated regulation as well as the
likelihood of alternative regulations. When this information can be identified and
realised in an intuitive manner, the reliability of regulatory information of peptides
and proteins can easily be evaluated. Such a strategy would certainly support the
detection of post-translational modifications.
Organisation of this Work This work is organised as follows: Section 2 gives
an overview of proteomics. Besides proteins and post-translational modifications
of those it focuses on the technique for measuring proteins and peptides quantita-
tively. Subsequently, the observed noise of the measurement is described followed
by the presentation of a specific noise model. After parameter estimation the
model assumptions and the parameter estimation are validated (section 3). Section
4 presents both a new approach for the calculation and visualisation of regulatory
information based on the established noise model as well as a resulting software
tool. A clustering strategy for the detection of unknown post-translational modi-
fications by the identification of differently regulated peptides within one protein
is introduced in section 5. This strategy is applied to an experimental dataset
exhibiting the correctness and potential of this approach. Finally, section 6 sum-
marises the results and provides an outlook on the future work.
2 Proteomics
The proteome – any proteins in a cell under defined conditions – is highly dynamic
and varies significantly regarding its qualitative and quantitative composition dur-
ing the cell cycle and changing environmental conditions. Besides identification
proteomics allows relative quantification of proteins and their fragments (peptides)
in cells using approaches from mass spectrometry. In the following, an introduction
to proteomics and the applied techniques is given which is necessary to understand
the biological background of this work.
2.1 Proteins
Proteins are the main actors within the cell and are found in all living systems
ranging from bacteria to higher mammals such as humans. Proteins are present in
greater amounts than any other biomolecule – more than 50% of the dry weight of
cells consists of them. Many of them are enzymes catalysing biochemical reactions,
others are regulatory proteins that contribute to the correct expression of the
genome. Some proteins are carriers moving molecules within or between cells and
others are structural proteins building cellular components. While the genome is
essentially identical in all cells within an organism, the set of expressed proteins
varies extensively through time in order to realise cellular function under variable
environmental conditions.
2.1.1 Composition of Proteins
Proteins are large organic compounds composed of 20 different amino acids which
are arranged in a chain. All types of amino acids have common structural features,
including a carbon to which an amino group, a carboxyl group, a hydrogen and an
amino acid specific side chain are bonded (Figure 2.11). The different side chains
account for the differing properties of amino acids, e.g. hydrophobicity and charge.
Consequently, the sequence of amino acids determines both biochemical properties
and function of a protein.
1taken from http://en.wikipedia.org/wiki/, 16.09.08
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Figure 2.1: General structure of amino acids. R represents a side chain which is specific to
each amino acid.
Amino acids can be abbreviated either by 3-Letter-Code (3LC) or by 1-Letter-
Code (1LC), which are listed in Table 2.1. The last column gives the mass of the
amino acids normally reported in units of daltons. One dalton is defined as 1
12
the
mass of carbon (12C). Protein sequence lengths fluctuate between about hundred
and many thousands of amino acids.
Table 2.1: Abbreviation of amino acids: 3-Letter-Code (3LC), 1-Letter-Code (1LC) as well
as specific masses.
Amino Acid 3LC 1LC Mass [Da] Amino Acid 3LC 1LC Mass [Da]
Alanine Ala A 71.0 Leucine Leu L 113.1
Arginine Arg R 156.1 Lysine Lys K 128.1
Asparagine Asn N 114.0 Methionine Met M 131.0
Aspartic acid Asp D 115.0 Phenylalanine Phe F 147.1
Cysteine Cys C 103.0 Proline Pro P 97.1
Glutamic acid Glu E 129.0 Serine Ser S 87.0
Glutamine Gln Q 128.1 Threonine Thr T 101.0
Glycine Gly G 57.0 Tryptophan Trp W 186.1
Histidine His H 137.1 Tyrosine Tyr Y 163.1
Isoleucine Ile I 113.1 Valine Val V 99.1
The individual amino acids are linked by peptide bonds. As both the amine and
carboxylic acid groups of amino acids can react to form amide bonds, one amino
acid molecule can react with another one and join through an amide linkage. In
this process one molecule of water (H2O) is released. The resulting CO–NH bond
is called a peptide bond. Formation of a peptide bond is shown in Figure 2.2.
2.1 Proteins 7
Figure 2.2: Formation of a peptide bond: one amino acid molecule can react with another
one and join through an amide linkage. In this process one molecule of water (H2O) is
released. The resulting CO–NH bond is called a peptide bond.
Short sequences comprising less then 50 amino acids are usually termed peptides.
Figure 2.32 illustrates a short peptide composed of five amino acids which are linked
by peptide bonds (green). Each of the amino acids has a side chain Rx, the end of
the sequence with a free amino group (left hand side, red) is termed the N-terminus
(amino terminus), whereas the end with a free carboxyl group (right hand side) is
known as the C-terminus (carboxy terminus, red).
Figure 2.3: Peptide consisting of five amino acids which are linked by peptide bonds (green).
Side chains are presented by Rx, N-terminus (left hand side) and C-terminus (right hand side)
are denoted in red.
Protein sequence lengths fluctuate between several hundreds and many thou-
sands of amino acids. The total mass of a protein is added up by the mass of the
comprising amino acids and is reported in dalton (Da) or kilodalton (kDa).
2.1.2 Protein Function
The function of a protein is based on its 3D structure which is determined by the
amino acid sequence and modification on the amino acids. All cellular functions
require proteins which for example are responsible for transportation processes,
work as hormones or act as antibodies for infection defence. Besides structural
proteins, the majority of proteins are enzymes and mediate nearly every type of
cellular function by controlling metabolic and signalling networks.
2.1.3 Modifications of Proteins
Different modifications occur and extend the range of protein functions. Thus,
from the same genetic locus different proteins are generated (alternative splicing).
2taken from Lodish et al. (1996)
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Also post-translational modifications (PTM) are able to alter the protein function
significantly. Often, PTM regulate molecular interactions of different proteins.
Post-translational modifications are modifications of proteins after the initial
synthesis of the whole protein (translation). Currently, about 200 different types
of modifications (Walsh et al., 2005) were described at proteins altering their struc-
ture, activity state, localisation, or stability. Hence, the range of functions of the
protein is extended by modifications accounting for removing the terminal part
of the sequence, adding new groups, and modifying existing groups such as the
oxidation of thiol groups. When the thiol groups of two cysteine residues are taken
close to each other in the course of protein folding, an oxidation reaction can cre-
ate a cystine unit with a disulfide bond (-S-S-) which can contribute to structural
changes of a protein. Other modifications, like phosphorylation, are part of com-
mon mechanisms for controlling the behaviour of a protein, for instance activating
or in-activating an enzyme.
2.1.4 Phosphorylation of Proteins
Phosphorylation of eucaryotic proteins can be detected as additional phosphate
group (PO3−4 ) to the amino acid residues serine (S), threonine (T), and tyrosine
(Y). Reversible phosphorylation of proteins is an important regulatory mechanism
which enzymes named kinases and phosphatase account for. Enzymes themselves
are often activated and deactivated by reversible phosphorylation. Adding and
removing a phosphate molecule strongly affects a protein’s polarity and structure.
In this way conformational changes in the structure of the protein are possible as
well as protein interactions by specific domains.
During phosphorylation phosphate groups from the high-energy molecule ATP
are transferred to specific target proteins by kinases. On the contrary, in the case
of dephosphorylation phosphate groups are removed from their substrates by phos-
phatases. Using any peptides as example phosphorylation and dephosphorylation
reaction is exemplified in Figure 2.4.
Figure 2.4: Phosphorylation and dephosphorylation reaction. The peptide
NGTDFGHSIPEYMHK is phosphorylated by a kinase and dephosphorylated by a phosphatase
at the amino acid tyrosine (Y).
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2.2 Mass Spectrometry
Mass spectrometry (MS) is used for measuring the masses of the molecules. How-
ever, mass spectrometers are only able to recognise charged molecules, therefore
the molecules must be ionised. In proteomics the ionisation is commonly achieved
by the addition of protons, and more rarely by loss of protons. Hence the mass
of the peptide or protein is increased and decreased by the nominal mass of 1 Da
multiplied by the number of charges (protons) in the case of addition and loss of
protons, respectively. By convention the number of added and lost protons is de-
noted by z resulting in positively and negatively charged ions. From the measured
mass/charge ratio (m/z ) of ions the molecular masses can be determined allowing
to identify the molecular composition of a given sample of analyte. In proteomics,
the analyte is usually a collection of peptides derived from a protein sample by
digestion with a protease like trypsin.
2.2.1 Instrumentation
Mass spectrometers consist of three basic components: an ion source, a mass
analyser and an ion detector. Ions are produced by transformation of the molecules
in the sample into ionised fragments. The ions are accelerated in an electric field
towards the analyser which separates the ions according to their mass/charge ratio.
The function of the detector is to record presence and “number” of individual ions.
Depending on the kind of ion source and mass analyser several different types of
mass spectrometers can be distinguished. The instrument which was used for the
generation of all data presented in this work, is explained in detail in the following.
Electrospray Ionisation Quadrupole Time Of Flight Mass Spectrometer In
the case of an Electrospray Ionisation Quadrupole Time Of Flight mass spectrome-
ter (ESI-QTOF) the ionisation is achieved by electrospray ionisation of appropriate
solvents containing the analytes. The analyte is dissolved and forced through a
narrow needle held at a high voltage. A fine spray of charged droplets emerges
from the needle and is directed into the vacuum chamber of the instrument. Enter-
ing the mass spectrometer, the droplets are dried using a stream of gas, resulting
in gas-phase ions.
The mass analyser consists of several quadrupole sections and an additional
time of flight analyser. A quadrupole is a set of four parallel metal rods with an
electric field in between. It can be operated in different modes, either allowing
ions of any m/z ratio to pass through, or in scanning mode, where a potential
difference is applied and the instrument acts as a mass filter. In the latter case,
ions of a selected m/z ratio are allowed to pass through to the detector whereas all
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others are deflected from their linear flight path and eliminated from subsequent
analysis. By varying the voltage over time, ions with different m/z ratios can be
selectively allowed through to the detector and a mass spectrum of the analyte
can be obtained. The included TOF analyser exploits the fact, that heavy ions
will take longer to travel down a field-free tube than lighter ones if all ions are
carrying the same charge.
Finally, the detector records the presence and “number” of individual ions. With
the aid of software the measurements are interpreted resulting in a mass spectrum
(see section 2.2.2, Figures 2.6 and 2.8).
2.2.2 Proteomics Approaches
Generally, proteomics approaches are divided into two types of strategies: top-
down proteomics and bottom-up proteomics. In the top-down approach, intact
proteins are directly used for the analysis and identified by its mass whereas in the
widespread bottom-up approach, proteins are first cleaved into peptides. These
peptides are introduced into the mass spectrometer and identified by peptide mass
fingerprinting or tandem mass spectrometry. Hence, bottom-up proteomics uses
identification at the peptide level to infer the existence of proteins.
Peptide Mass Fingerprinting Peptide mass fingerprinting (PMF) or peptide
mapping refers to the identification of proteins using measured peptide masses.
The principle of this technique is that each protein can be identified by the masses
of its peptides. For the generation of peptides from the proteins of the sample,
the proteins have to be digested with a specific cleavage reagent, usually trypsin.
Trypsin predominantly cleaves peptide chains at the carboxyl side of the amino
acids lysine (K) and arginine (R) as illustrated in Figure 2.5.
Figure 2.5: Cleavage sites of a polypeptide chain by trypsin which cleaves peptide chains
at the carboxyl side of the amino acids lysine (K) and arginine (R).
Subsequent to the measurement the obtained peptide masses are compared with
theoretical peptide masses of known proteins (in-silico digest) which are derived
from the amino acid masses (see Table 2.1). Indeed, the obtained peptide masses
do not yield in unique identification of the peptides since peptides containing equal
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amino acids in different orders have the same masses. Even completely different
peptides sometimes have very similar masses that are not able to be distinguished
perfectly. Figure 2.6 shows a spectrum obtained by peptide mass fingerprinting.
Different peptides are identified by different detected masses. The x-axis refers to
m/z, the y-axis refers to the intensity which was measured by the detector. Each
peak represents a particular peptide from the protein. It should be mentioned,
that due to different peptide properties the peak heights do not correlate with the
amounts of different peptides in PMF.
Figure 2.6: Mass spectrum containing several different peptides obtained by peptide mass
fingerprinting. The x-axis refers to m/z, the y-axis refers to the intensity which was measured
by the detector. Each peak represents a particular peptide from the protein.
Peptide Sequencing by Tandem Mass Spectrometry Spectra of peptides
generated by tandem mass spectrometry (MS/MS) may provide significant in-
formation for the determination of the amino acid composition within the peptide
(peptide sequencing) in contrast to spectra generated by MS. By using two mass
analysers in series separated peptides fragment at predetermined breaking points
into corresponding ions (Figure 2.7). Depending on the used MS device ions from
particular series are more or less frequent.
12 2 Proteomics
Figure 2.7: Breaking points of peptides during fragmentation in MS/MS. Different kinds
of ions can be generated. Depending on the breaking point the ions are called a/x, b/y and
c/w ions.
The amino acids of a peptide can be derived from the measured fragment ion
masses. The correct order of the total or at least parts of the sequence are deter-
mined by comparing detected masses and known amino acid masses, considering
that ions may contain more than one amino acid (Figure 2.8). Nowadays, this work
combined with comparisons of the obtained results with theoretically peptides is
done routinely by software.
Figure 2.8: Peptide sequencing: Annotated peptide mass spectrum generated by MS/MS.
Each amino acid of the peptide is represented by specific mass (m/z, x-axis).
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2.2.3 Combination of Mass Spectrometry and
Chromatographic Techniques
In the case of complex samples containing more than one or a few proteins, sepa-
ration of the analyte is helpful. Different chromatographic separation techniques
are recommended depending on the analysed compounds. Before the peptides are
subsequently introduced into the mass spectrometer, liquid chromatography (LC)
is performed in order to separate the peptides (LC-MS/MS).
2.3 Quantification of Peptides and Proteins
Besides identification, mass spectrometry can be used for relative and absolute
quantification of proteins. Comparative analyses are performed in order to reveal
proteins regulated under specific conditions and to define involved networks, pro-
cesses and signalling pathways. LC-MS/MS typically investigates protein-derived
peptides. Thus strategies for the quantification and characterisation of proteins
preferentially should assess the peptide level.
iTRAQTM (Isobaric Tag for Relative and Absolute Quantitation) – introduced
by Ross et al. (2004) – became one of the standard techniques for relative quan-
tifications of automatically sequenced peptides. iTRAQTM allows relative as well
as absolute peptide quantification of up to eight different samples in parallel us-
ing up to eight differential labelling reagents (Pierce et al., 2008). During the
labelling process the selected type of iTRAQTM molecules is covalently linked to
every peptide from one biological sample. All eight iTRAQTM molecules have
the same structure and molecular weight, but differ in the distribution of incor-
porated isotopes (Figure 2.9). In the intact molecule the total mass is balanced
by the so-called balancer group and each labelling reaction introduces an iden-
tical mass shift. However, under the conditions of peptide sequencing (MS/MS)
iTRAQTM also produces fragment ions that differ in mass and serve as sample spe-
cific reporters: Same peptides (with identical amino acid sequence) from different
biological samples which were labelled differentially and are subsequently pooled
exhibit the same biochemical properties and total masses. Consequently, identical
peptides from different samples co-elute at the same time from chromatographic
columns, enter with the same molecular weight the MS device and are subjected
commonly to the fragmentation process. The ratios of the released iTRAQTM re-
porter ions correlate with the relative abundance of the analysed peptides as part
of the investigated samples.
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Figure 2.9: Chemical constitution of the iTRAQTM molecules (taken from Pierce et al.
(2007)). A: Reporter group, balance group and reactive group. B: Eight variants of
iTRAQTMmolecules resulting in total masses 113.1 – 119.1 Da and 121.1 Da.
A typical iTRAQTM workflow allowing the relative quantification of peptides de-
rived from proteins of two different samples is summarised in Fig. 2.10. Initially,
all proteins from both samples are cleaved into peptides by a specific endo-protease
(e.g. digestion with trypsin). Thereafter, both peptide fractions are labelled sepa-
rately using different iTRAQTM reagents each containing reporter groups of differ-
ent masses (e.g. 114.1 Da or 116.1 Da). iTRAQTM molecules are linked covalently
to the N-terminus of each peptide as well as to every present lysine in the peptide
sequence. Identical peptides from different samples exhibit a modified but identical
chemical behaviour and mass subsequent to the iTRAQTM labelling. Therefore,
differentially labelled samples can be pooled before the MS analyses. Whereas
the amino acids of peptides from both samples commonly contribute to the total
ion intensities used for the peptide sequencing, the reporters dissociate in sample-
specific amounts. Reporter ions with specific masses (113.1 Da, 114.1 Da, 115.1
Da, 116.1 Da, 117.1 Da, 118.1 Da, 119.1 Da, 121.1 Da, see Figure 2.9) can be
detected as part of every peptide fragmentation spectrum and a direct comparison
of their intensities gives information about the relative abundance of peptides in
the compared samples.
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Figure 2.10: iTRAQTM workflow: proteins from samples A and B are digested, pep-
tides (red) are iTRAQTM labelled (tags 114.1 and 116.1) and combined. When performing
LC-MS/MS peptide bonds between the amino acids as well as bonds between iTRAQTM
molecules and peptides are broken. Subsequently, peptides are used for identification and
iTRAQTM molecules are used for relative quantification.
Figure 2.11 shows reporter intensity peaks of one peptide from two differentially
labelled samples within an MS/MS spectrum. The iTRAQTM -reporters 114.1 and
116.1 are used for peptide labelling and are detected with most intense peaks.
Small signals at m/z 115.1 and 117.1 are caused by specified impurities of the
reagent. Regarding the percentage intensities on x-axis the peptide of this spec-
trum was found about 20 times more frequently in the 116.1 labelled sample than
in the 114.1 labelled sample.
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Figure 2.11: MS/MS spectrum of a peptide labelled with iTRAQTM reagents 114.1 and
116.1. Regarding the percentage intensities on x-axis the peptide is detected nearly 20 times
more frequent in the 116.1 labelled sample than in the 114.1 labelled sample (extended re-
porter mass region in the lower part of the figure).
The upper MS/MS spectrum shows intensity peaks based on areas. Stick spectra
are generated from those profile spectra by centering. Previous tests yielded that
relative proportions are not changed by centering (data not shown). Regulatory
information can be presented as ratios (regulation factor, expression ratio), which
are calculated from pairwise comparisons of iTRAQTM reporter ions of peptides
from all samples. According to the measured intensities of the peptide shown in
2.4 Experimental Data and Data Processing 17
Figure 2.11 the regulation factor is about 20 ( 1
20
) since the peptide is detected
nearly 20 times more frequent in the 116.1 labelled sample than in the 114.1
labelled sample.
2.4 Experimental Data and Data Processing
Most of data presented in section 5 were generated from HGF stimulated human
epithelial cells and untreated control cells (HGF/Met-activated signalling studies).
Peptides were separated using a nanoAcquity HPLC (Waters Corp., USA) that was
linked to a Q-TOFmicro mass spectrometer (Waters Corp., USA). Postprocessing
of fragmentation data contained combination of 4 MS scans to one spectrum,
smoothing based on Savitzki-Golay and generation of centroid spectra. MS data
that were acquired and processed by MassLynx (version 4.1, Waters Corp., USA)
were searched for protein identification using the UniProtKB/Swiss-Prot database
(release 55.0 of 26-Feb 2008 with 356194 entries; taxonomy: Homo sapiens with
18610 entries) and Mascot Daemon 2.1.6. Only peptides that were unambiguously
sequenced and identified (Mascot V 2.1, Matrix Science, Perkins et al. (1999))
were included in the statistical evaluation of regulatory data.
3 iTRAQTM -specific Noise Model
Often, measuring biological components generates results corrupted by noise. Noise
can be caused by various factors as the detector itself, amplifier circuits, sample
properties or data processing and appears independently of the applied technology
(i.e. microarray, mass spectrometry). In contrast to microarray data examined
in detail concerning their impairment by noise (e.g. Baldi and Long (2001)) such
investigations of mass spectrometry data – especially quantitative data generated
with the new technology iTRAQTM – are just in the beginning. Noise models for
microarray data are enjoying great popularity for some years already (e.g. Rocke
and Durbin (2001); Tu et al. (2002); Weng et al. (2006)), whereas the development
of more precise noise models for MS data has only started recently (Anderle et al.,
2004; Du et al., 2008). Only a few studies regarding iTRAQTM specific noise can
be found in literature (Hu et al., 2006; Lin et al., 2006; Boehm et al., 2007). In all
cases, it was observed and assumed that noise depends on the measured intensity.
3.1 Data Preprocessing
Preprocessing is a necessary step before the data are used for model building or
analysis. In the case of iTRAQTM data preproccesing at least contains the cor-
rection of isotopic impurities and sample normalisation. Sample normalisation is
investigated in-depth for several types of data (e.g. Bolstad et al. (2003)). Besides
a few approaches concerning the development of iTRAQTM specific noise models
that introduce preprocessing, D’Ascenzo et al. (2008) presented a software pack-
age focusing on preprocessing and visualisation of 8-plex iTRAQTM labelled data.
Several transformations like the correction of isotopic impurities and different nor-
malisation strategies can be performed user-defined.
Before analysing data in this work, an improved peak detection as well as iso-
topic impurity correction, sample normalisation and logarithmic transformation
are applied to quantitative data postprocessed as described in section 2.4. From
such data the actual iTRAQTM reporters are read out using Mascot Parser 2.1.00
(Matrix Science), which is an object-oriented Application Programmer Interface
(API) to both Mascot result and configuration files. In detail, the performed
preprocessing items are:
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1. Peak detection
If only one signal corresponds to each iTRAQTM reporter within a range of
reporter mass ± 0.05Da, this signal is selected as reporter intensity. How-
ever, in case of multiple signals near the specified mass an optimised algo-
rithm for peak detection is applied: The mass ranges of all used reporters
are scanned for the existence of a mass pattern that contains signals com-
prising exact differences (1 Da) of the expected masses. Figure 3.1 illus-
trates this approach: Two signals are detected near the expected mass of
the iTRAQTM label 115.1. Even though the higher signal (mass ∼ 115.1 Da)
matches better the expected mass, the lower signal (mass ∼ 115.05 Da) is
selected by the algorithm. The signal ∼ 115.05 Da is more reliable since
signal intensities comprising 1 Da mass differences are detected (114.05 Da,
116.05 Da, 117.05 Da). Obviously, a mass shift appeared and is compensated
by this new algorithm for peak detection.
Figure 3.1: Multiple possible signals corresponding to iTRAQTM label 115.1. Due to the
presence of a pattern of 1 Da the lower intensity is selected by the optimised algorithm for
peak detection.
2. Correction of isotopic impurities
Each iTRAQTM reporter type can contribute to the neighbouring signals with
a few percent of its own ion intensity (isotopic impurity). A small fraction of
each iTRAQTMmolecule batch is routinely subjected to individual fragmen-
tation experiments in order to certify its signal specificities. Afterwards, the
percentage of certified isotopic impurities of each applied iTRAQTMmolecule
type is introduced in a linear system of equations. This allows to calculate
precisely the actual ion abundances of differently labelled peptides.
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Based on the measurement of signal intensities as given in Table 3.1 and
transformations as exemplified with iTRAQTM 114.1 in (3.1) a system of
linear equations is obtained. Variables a . . . d and indices −2 · · ·+ 2 refer to
the percentages of the true total intensity (i(c)11x.1) and i11x.1 corresponds to
the measured intensity at mass 11x.1 Da.
Table 3.1: Presentation of signal intensity measurements: Intensities of each
iTRAQTM reporter and its neighbouring masses in a distance of −2 Da, −1
Da, +1 Da and +2 Da are necessary for the calculation of isotopic impurities.
iTRAQTM reporter mass−2 Da mass−1 Da mass mass+1 Da mass+2 Da
iTRAQTM 114.1 a−2 a−1 a0 a+1 a+2
iTRAQTM 115.1 b−2 b−1 b0 b+1 b+2
iTRAQTM 116.1 c−2 c−1 c0 c+1 c+2
iTRAQTM 117.1 d−2 d−1 d0 d+1 d+2
Using iTRAQTM 114.1 as an example, the performed transformations are
i
(c)
114.1
= i114.1 + a−2i
(c)
114.1 + a−1i
(c)
114.1 + a+1i
(c)
114.1 + a+2i
(c)
114.1 − b−1i(c)115.1 − c−2i(c)116.1
= i114.1 + (a−2 + a−1 + a+1 + a+2)i
(c)
114.1 − b−1i(c)115.1 − c−2i(c)116.1
⇐⇒
i114.1 = (1− a−2 − a−1 − a+1 − a+2)i(c)114.1 + b−1i(c)115.1 + c−2i(c)116.1. (3.1)
Similar transformations with intensities of iTRAQTM reporters 114.1 . . . 117.1
yield the following system of linear equations comprising four equations and
four variables.
i114.1 = (1− a−2 − a−1 − a+1 − a+2)i(c)114.1 + b−1i(c)115.1 + c−2i(c)116.1
i115.1 = a+1i
(c)
114.1 + (1− b−2 − b−1 − b+1 − b+2)i(c)115.1 + c−1i(c)116.1 + d−2i(c)117.1
i116.1 = a+2i
(c)
114.1 + b+1i
(c)
115.1(1− c−2 − c−1 − c+1 − c+2)i(c)116.1 + d−1i(c)117.1
i117.1 = b+2i
(c)
115.1 + c+1i
(c)
116.1 + (1− d−2 − d−1 − d+1 − d+2)i(c)117.1 (3.2)
3. Normalisation
Normalisation of samples is done by comparing the trimmed mean values of
all iTRAQTM intensities of every sample and adjusting the intensities of all
samples with high peptide concentration to those of the lowest concentration
by multiplicative correction. For the calculation of the normalisation factor
the mean value was calculated after discarding the upper and lower 20%
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of the sample’s intensities (trimmed mean). In contrast to mean value or
median, the trimmed mean is nearly untouched by heavy regulations of single
peptides as well as regulation of significant amounts of the samples.
4. Logarithmic transformation
The last preprocessing step is logarithmic transformation of signal intensities.
3.2 iTRAQTM specific Noise
Routinely and in accordance with Hu et al. (2006), Lin et al. (2006) and Boehm
et al. (2007) an ion intensity dependent accuracy of regulatory data is observed.
This effect can be representatively investigated and visualised by using the fol-
lowing test system: a protein sample is digested, split and the resulting peptides
are labelled differentially with two different iTRAQTM tags (e.g. 115.1 and 117.1)
before both fractions are re-combined in a 1:1 ratio and analysed by LC-MS/MS.
After preprocessing (section 3.1) logarithmic peptide ratios are derived and plot-
ted against the mean of the logarithmic reporter intensities 115.1 and 117.1 as
presented in Figure 3.2. Calculation of ratios is performed by taking the loga-
rithm of the reporter intensity quotient 115.1
117.1
. The peptide expression accuracy is
iTRAQTM reporter ion intensity dependent. Decreasing iTRAQTM reporter ion
intensities coincide with increased deviations from the expected 1:1 ratios.
Figure 3.2: Intensity dependent noise of iTRAQTM data: decreasing iTRAQTMreporter
ion intensities coincide with increased deviations from the expected 1:1 ratios. Logarithmic
peptide ratios are plotted against the mean of the logarithmic reporter intensities 115.1 and
117.1.
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3.3 Noise Model
Analysis of an unregulated sample – where all peptides are expected to be unreg-
ulated and therefore all ratios are expected to be 1 – produces strongly deviating
regulations as shown in Figure 3.2. The quality of the derived regulatory infor-
mation depends on the signal intensity. Less reliable regulation factors originating
from low signal intensities are to be identified and for subsequent interpretation of
biological results they are to be weighted less than regulatory information derived
from high intensities. For performing this task a model is necessary that returns
the possible deviation of regulation factors depending on the measured intensities.
3.3.1 Modelling
Available data Each intensity is measured several times. In the ideal case with-
out noise, all measurements should be identical. Since noise cannot be ruled out,
it is impossible to know the true intensities. The intensity range depends on prop-
erties of the analysed peptides as well as the used device.
Model Assumptions The noise follows a log-normal distribution and its vari-
ance depends on the (true, unknown) intensity. It does not seem appropriate to
assume a normal distribution of the noise directly, since intensities are always non-
negative. Since calculations are much easier with normal distributions, in most
cases logarithms of data are used for further calculations. For the raw data and
random variables associated with them the letters x and X are used, respectively,
for the transformed data and their associated random variables the letters y and
Y , respectively.
The general problem to be solved is as follows. A data set of the form(
y
(1)
1 , . . . , y
(k1)
1 , . . . , y
(1)
n , . . . , y
(kn)
n
)
is given. y(1)i , . . . , y
(ki)
i represent ki noisy mea-
surements of the same (logarithmic) unknown intensity µi.
It is assumed that the subsample y(1)i , . . . , y
(ki)
i originates from independent sam-
ples of a normal distribution with unknown mean µi and unknown variance σi.
From experiments it is known that the variances follow a certain tendency. Small
intensities are less reliable (more noisy) than larger ones. In order to take this into
account, it is assumed that
σ(µ) = a+ re−λµ (3.3)
with a, r, λ ≥ 0.
a represents the absolute noise in the measurement that is always present. r
specifies the amount of relative noise depending on the (logarithmic) intensity µ.
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λ determines how fast the relative noise decreases with increasing (logarithmic)
intensity.
3.3.2 Parameter Estimation
Parameter estimation is part of inferential statistics which aims on drawing con-
clusions about a population based on a sample. Maximum likelihood estimation
(MLE) is a popular statistical method – with nice asymptotic properties – for
the estimation of unknown parameters of a probabilistic model based on a set
of observed data. The maximum likelihood estimator tries to find values for the
unknown parameter to make the observation as probable as possible.
3.3.2.1 Principle of Maximum Likelihood Estimation
For a fixed set of observed data (x1, . . . xn) and underlying probability model, the
maximum likelihood estimation determines the values of the model parameters θ
that make the data “most likely”. A small example illustrates the approach with
normally distributed data.
Assumptions:
1. X is a random variable with a random sample x1, ..., xn following a normal
distribution N (µ, σ2).
2. θ is the unknown parameter or parameter vector that is to be estimated.
The likelihood function equals the product of the densities corresponding to the
observed values:
L(θ) =
n∏
i
f(xi | θ) (3.4)
Values of θ maximising this function are called “maximum likelihood estimator”.
For the normal distribution N (µ, σ2) which has the probability density function
(pdf)
fX(x) =
1
σ
√
2pi
e
−(x−µ)2
2σ2 (3.5)
the likelihood is
L(θ) = L(x1, . . . , xn | θ) =
n∏
i=1
1
σ
√
2pi
e
−(xi−µ)2
2σ2 =
1
(2piσ2)
n
2
e−
1
2σ2
Pn
i=1(xi−µ)2 . (3.6)
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The method of maximum likelihood estimates θ by finding the value(s) of θ
that maximise(s) L(θ) and therefore, that return(s) the highest probability for the
random sample x1, . . . , xn. The maximisation of the likelihood is usually carried
out by finding the root of the derivative of the likelihood. The likelihood consists
of multiplications and therefore, differentiation is a challenging task. The max-
imisation of the log-likelihood is equivalent to the maximisation of the likelihood
itself. Since differentiation of the log-likelihood – consisting of summation instead
of multiplication – is less complex, the log-likelihood is considered.
ln(L(x1, . . . , xn | θ)) = −n
2
ln(2piσ2)− 1
2σ2
n∑
i=1
(xi − µ)2 (3.7)
It is not always possible to find an analytical solution for the root of the deriva-
tive for the maximum likelihood estimator. In such cases other strategies from
optimisation theory are to be applied to find the maximum likelihood estimator.
3.3.2.2 Maximum Likelihood Estimation of a, r and λ
The aim is to estimate the parameters a, r and λ based on the sample(
y
(1)
1 , . . . , y
(k1)
1 , . . . , y
(1)
n , . . . , y
(kn)
n
)
. Unfortunately, this requires that µi is esti-
mated for each subsample y(1)i , . . . , y
(ki)
i . It is known that the values in the sub-
sample are noisy measurements of the same intensity µi, but µi itself is unknown.
According to the principle of maximum likelihood the parameter estimation is
performed by maximising the likelihood
L
(
y
(1)
1 , . . . , y
(k1)
1 , . . . , y
(1)
n , . . . , y
(kn)
n |a, r, λ
)
=
n∏
i=1
ki∏
j=1
1
(a+ re−λµi)
√
2pi
exp
(
− (y
(j)
i − µi)2
2(a+ re−λµi)2
)
. (3.8)
The factors are the densities of normal distributions with mean µi and deviation
σ(µi) = a+ re
−λµi .
The maximisation of L does not only involve the determination of the parameters
a, r and λ, but also the estimation of the µi values. Assuming the parameters a, r
and λ to be fixed at the moment, the µi-values can be optimised independently.
This means the log-likelihoods
L˜i =
ki∑
j=1
(
− ln(
√
2pi)− ln(h(µi))− (y
(j)
i − µi)2
2(h(µi))2
)
(3.9)
where h(µi) = a + re−λµi are to be maximised. In order to maximise L˜i it is
necessary that
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dL˜i
dµi
=
ki∑
j=1
(
− h
′(µi; θ)
h(µi; θ)
+
(x
(j)
i − µi)(h(µi; θ) + (x(j)i − µi)h′(µi; θ))
h3(µi; θ)
)
= 0
(3.10)
holds. With h′(µi) = −λre−λµi and multiplying (3.10) by (a+ re−λµi)3
ki∑
j=1
(
(λre−λµi)(a+ re−λµi)2 + (x(j)i − µi)((a+ reλµi) + (x(j)i − µi)(−λre−λµ)
)
= 0
(3.11)
is obtained. Solving (3.11) for µi yields the maximum likelihood estimation for
µi, assuming the parameters a, r and λ to be fixed. This is done numerically by
a simple bisection strategy. As one boundary for bisection, the mean value of the
y
(j)
i is chosen. The second one is determined by systematically searching left and
right from this value until the sign of (3.11) changes. The optimisation of the
parameters a, r and λ is carried out by an evolution strategy (Bäck, 1996).
Evolution Strategy Evolution strategies are search and optimisation methods
using mutation, recombination, and selection applied to a population of individu-
als containing candidate solutions in order to evolve iteratively better and better
solutions. The principle of evolution contains
1. initialisation of a parent population
2. generation of an offspring population by recombination and variation of ex-
isting elements (“mutation”)
3. selection of a new parent population from either the offspring population or
the union of offspring and parent population.
The mutation and selection steps are repeated until the termination criterion is
fulfilled.
For the optimisation of the parameters a, r and λ the applied evolution strategy
has an adaptive mutation rate and population size = 10, offspring size = 25. The
mutation of the parameters (offsprings) is given by adding a normally distributed
random number which is influenced by the mutation rate. The algorithm termi-
nates after 100 generations or if 20 generations could not achieve an improvement
of fitness. The fitness of a parameter combination (a, r, λ) is given by (3.8), where
the µi are determined as described above based on solving (3.11).
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3.3.3 Training
The parameters a, r, and λ directly depend on the type of the mass spectrometer
in general as well as on data acquisition settings. Parameter estimation for every
analysis dataset individually causes problems concerning (i) the low number of
samples, (ii) optionally comprised regulated peptides and last but not least (iii)
extension of runtime for each analysis. Particularly the low number of samples –
usually two samples are analysed which is not enough for statistical calculations
– is an important aspect. To estimate the parameters a, r, λ a training dataset
is generated. Five peptides are used to determine the intensity dependent noise.
Two unmodified peptides and three phosphopeptides are included in this approach
which facilitate to cover a broad dynamic reporter intensity range. Measurements
are repeated 23 times (sample size ki = 23 for all i) for all five peptides. By
using different collision energies for the measurements, different absolute levels of
iTRAQTM reporter intensities are obtained. In this way 23 reporter intensity vari-
ations at 24 different intensity levels resulting in 552 individual reporter intensities
are repeatedly measured.
From this dataset the noise parameters were estimated for the used instru-
ments and postprocessing settings (compare section 2.4) as follows: a = 0.0103,
r = 0.9908 and λ = 0.4751.
Table 3.2 itemises the sample ID, the peptide sequence as well as the applied
collision energy for every of the 24 subsets of the training dataset. Tables 3.3
and 3.4 show measured intensities, mean intensity and standard deviation of every
subset.
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Table 3.2: Subset ID, peptide sequence and applied collision energy of the 24 subsets of the
training dataset. Phopshorylated amino acids are coloured.
Subset ID Sequence collision energy [eV]
Z4298A FVLDDQYTSSTGTKFPVK 34.5
Z4299 FVLDDQYTSSTGTKFPVK 30
Z4299A FVLDDQYTSSTGTKFPVK 25
Z4299D FVLDDQYTSSTGTKFPVK 35
Z4300A SSTVTEAPIAVVTSR 30
Z4300B SSTVTEAPIAVVTSR 40
Z4300n SSTVTEAPIAVVTSR 35
Z4309 HERPAGPGTPPPDSGPLAK 25
Z4309C HERPAGPGTPPPDSGPLAK 22
Z4309A HERPAGPGTPPPDSGPLAK 28
Z4309B HERPAGPGTPPPDSGPLAK 30
Z2232 VSDFGLTK 30
Z2233 VSDFGLTK 28
Z2234 VSDFGLTK 26
Z2235 VSDFGLTK 25
Z2236 VSDFGLTK 22
Z2240 VSDFGLTK 12
Z2241 IADPEHDHTGFLTEYVATRWYR 37.8
Z2242 IADPEHDHTGFLTEYVATRWYR 37.8
Z2243 IADPEHDHTGFLTEYVATRWYR 37.8
Z2244 IADPEHDHTGFLTEYVATRWYR 35
Z2245 IADPEHDHTGFLTEYVATRWYR 33
Z2246 IADPEHDHTGFLTEYVATRWYR 32
Z2247 IADPEHDHTGFLTEYVATRWYR 30
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3.3.4 Validation of the Noise Model
Several assumptions were made for the development of the noise model, especially
(i) log-normally distributed intensities and (ii) the definition of the standard de-
viation by σ(µ) = a + reλµ. These assumptions are to be verified. This can be
performed by application of statistical tests to the underlying data as well as sim-
ulation of data corresponding to the proposed model. Furthermore, the so-called
“95% Interval” can be used for the comparison of the expected deviation according
to the model and the deviation of an unregulated sample.
3.3.4.1 Verification of Assumptions
By the means of several statistical techniques the verification of the made assump-
tions is realised. Primarily, statistical tests and simulation of data generated by
the proposed model and the estimated parameters (3.3.3) are applied.
Testing for Normal Distribution
For testing whether the noise follows a log-normal distribution, the logarithmic
intensities of each subset of the training dataset is tested for following a normal
distribution. Therefore, in the following logarithmic intensities are regarded. First
of all, two statistical tests checking the goodness-of-fit are applied and additionally
quantile-quantile plots are generated for each subset.
Statistical hypothesis tests calculate the probability of an observation assuming
the null hypothesis is valid. This involves the test of a null hypothesisH0 against an
alternative hypothesis H1. For example, the null hypothesis could be “the observed
data follow a normal distribution”. In that case, the alternative hypothesis would
be “the observed data do not follow a normal distribution”. According to the applied
test statistic the probability of the observation is computed assuming that the null
hypothesis is valid. If this value, also known as p-value, is less than the defined
significance level (e.g. 5% and 0.05, respectively), the null hypothesis is rejected
in behalf of the alternative hypothesis. Otherwise, the null hypothesis can not be
rejected, which is no proof of its validity. For details see for example W. J. Ewens
(2002).
Both Shapiro-Wilk-Test and Kolmogorov-Smirnov-Test are goodness-of-fit-tests
that are able to check whether the assumption of a sample being normally dis-
tributed has to be rejected or not.
Shapiro-Wilk-Test The Shapiro-Wilk-Test (Shapiro and Wilk, 1965) checks the
assumption that a random sample was drawn from a normal distribution. Accord-
ing to L. Sachs (2006) the Shapiro-Wilk-Test has the highest power (probability
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of rejecting a false null hypothesis) in comparison with other statistical tests. It is
most reliable for small sample sizes (n < 50).
The results achieved by application of Shapiro-Wilk-Test to the subsets of the
training dataset are in almost all cases the same: The null hypothesis “the in-
tensities of the subsets follow a normal distribution” can not be rejected. Just
subset Z2233 achieved a p-value < 0.05 and thus is not regarded to be normally
distributed.
Kolmogorov-Smirnov-Test The Kolmogorov-Smirnov-Test (K-S-Test) – devel-
oped in the 1930s – allows the comparison of an assumed distribution to some
other known distribution. Unlike Shapiro-Wilk-Test it is possible to test for differ-
ent distributions, for example the normal distribution. If the assumed distribution
is not completely known, e.g. if the expectation value and/or the variance are
estimated, the results of the K-S-Test are inaccurate (L. Sachs, 2006).
K-S-Test returned that the intensities of no subsets follow a normal distribution.
Regarding the comments of L. Sachs (2006) concerning the accuracy of this test
when expectation value and variance are estimated – as in the case of the analysed
subsets – these results are weighted less than the results of Shapiro-Wilks-Test.
Results
The calculated p-values of all subsets obtained by Shapiro-Wilk-Test and K-S-Test
are summarised in Table 3.5.
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Table 3.5: Comparison of the resulting p-values of Shapiro-Wilk-Test and Kolmogorov-
Smirnov-Test. Regarding Shapiro-Wilk-Test the null hypothesis “the intensities of the subsets
follow a normal distribution” can not be rejected, whereas K-S-Test determines the opposite.
Subset ID Shapiro-Wilk-Test Kolmogorov-Smirnov-Test
Z4298A 0.76 1.3e−4
Z4299 0.19 3.4e−4
Z4299A 0.05 2e−5
Z4299D 0.38 1.8e−4
Z4300A 0.69 3.7e−4
Z4300B 0.40 3.7e−4
Z4300n 0.23 5e−5
Z4309 0.06 6.5e−5
Z4309C 0.24 2.73e−3
Z4309A 0.06 8e−7
Z4309B 0.81 7e−6
Z2232 0.53 8e−7
Z2233 0.04 2e−7
Z2234 0.51 2.4e−6
Z2235 0.51 2e−7
Z2236 0.98 2e−5
Z2240 0.31 1.75e−3
Z2241 0.37 3.5e−7
Z2242 0.07 8e−7
Z2243 0.13 2e−6
Z2244 0.32 5.5e−5
Z2245 0.75 7e−5
Z2246 0.78 1.6e−4
Z2247 0.59 3.8e−4
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Quantile-Quantile Plots Since the results of the applied goodness-of-fit-tests
are inconsistent, an additional test for checking the assumption is performed. A
quantile-quantile plot (Q-Q plot) is a graphical method for diagnosing differences
between the probability distribution of a statistical population (from which a ran-
dom sample has been taken) and a comparison distribution. The quantiles of the
sample are plotted against the theoretical quantiles of the comparison distribution
where a q-quantile is given by xq = P (X ≤ xq). If the n points (n = sample
size) approximate a straight line, the population distribution is the same as the
comparison distribution. In the case of using a normal distribution as comparison
distribution the plots are called “normal Q-Q plots”.
Figures 3.3 and 3.4 show normal Q-Q plots for data following a normal distribu-
tion (Figure 3.3) and for data following a uniform distribution (3.4). In contrast
to uniformly distributed data, the normally distributed data approximately fit a
line.
Figure 3.3: Examples of a normal Q-Q plot for data following a normal distribution. The
sample quantiles are plotted against the theoretical quantiles approximating a line.
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Figure 3.4: Example of a normal Q-Q plot for data following a uniform distribution. The
sample quantiles are plotted against the theoretical quantiles not approximating a line.
The following figures (Figure 3.5 – Figure 3.7) show the normal Q-Q plots for
all subsets of the training dataset. Most of them confirm or – at least – are not
contrary to the assumption that the logarithmic intensities are following a normal
distribution and consequently, that the intensities are log-normally distributed.
Figure 3.5: Normal Q-Q plots of the subsets Z2232, Z2233, Z2234, and Z2235. The sample
quantiles are plotted against the theoretical quantiles.
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Figure 3.6: Normal Q-Q plots of the subsets Z2236, Z2240, Z2241, Z2242, Z2243, Z2244
Z2234, Z2246, Z2247 and Z4298A. The sample quantiles are plotted against the theoretical
quantiles.
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Figure 3.7: Normal Q-Q plots of the subsets Z4299A, Z4299D, Z4299, Z4300A, Z4300B,
Z4300n, Z4309A, Z4309B, Z4309C and Z4309. The sample quantiles are plotted against the
theoretical quantiles.
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Simulations
The applied simulations provide a basis for checking the proposed noise model.
Especially the assumption of the standard deviation σ(µ) = a+re−λµ is verified in
this way. Both simulations have in common that the estimated parameter values
are used for the generation of datasets and the results are compared with results
achieved by analysis of the test dataset.
Comparison of Variances The variances of the subsets of the training dataset
and a simulated dataset generated by the noise model are compared to each other.
On the one hand, the mean value and the variance of every subset are calcu-
lated (Table 3.6, columns “mean subset” and “var subset”). On the other hand,
corresponding to every subset 100 normally distributed random numbers are gen-
erated with a mean value equal to the mean value of the regarded subset. From
this dataset the mean value and the variance are determined (Table 3.6, columns
“mean model” and “var model”) with var model = σ2(µ) = (a+re−λµ)2, a = 0.0103,
r = 0.9908 and λ = 0.4751 (as estimated, compare section 3.3.2). The results are
given in Table 3.6. In summary, the deviations of mean values and variances of the
training dataset subsets and the simulated datasets are smallish (mean deviation
= 0.0018) and therefore, serve as a first confirmation of the assumption σ2(µ) =
(a+ re−λµ)2.
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Table 3.6: Comparison of variances of the training dataset’s subsets and simulated subsets
with µ = mean value of subset and σ2(µ) = (a + re−λµ)2. The last column refers to the
differences.
Sample ID mean subset var subset mean model var model |var subset - var model|
Z4298A 4.4572 0.0168 4.4358 0.0167 0.0001
Z4299 5.5751 0.0065 5.5733 0.0078 0.0013
Z4299A 3.9850 0.0254 3.9955 0.0280 0.0026
Z4299D 6.4815 0.0031 6.4912 0.0028 0.0003
Z4300A 3.7109 0.0325 3.7311 0.0372 0.0047
Z4300B 5.4725 0.0070 5.4810 0.0065 0.0005
Z4300n 4.7784 0.0127 4.7675 0.0119 0.0008
Z4309 4.5469 0.0155 4.5360 0.0149 0.0006
Z4309C 3.5984 0.0359 3.5746 0.0332 0.0027
Z4309A 5.3570 0.0076 5.3573 0.0100 0.024
Z4309B 5.7613 0.0055 5.7634 0.0057 0.0002
Z2232 9.5890 0.0004 9.5898 0.0004 0.0000
Z2233 9.3795 0.0005 9.3783 0.0004 0.0001
Z2234 9.0830 0.0006 9.0830 0.0007 0.0001
Z2235 8.6686 0.0007 8.6662 0.0007 0.0000
Z2236 8.1551 0.0010 8.1567 0.0011 0.0001
Z2240 4.6877 0.0137 4.6709 0.0130 0.0007
Z2241 7.2158 0.0018 7.2182 0.0017 0.0001
Z2242 7.1662 0.0019 7.1709 0.0020 0.0001
Z2243 7.0925 0.0020 7.0947 0.0022 0.0002
Z2244 6.6377 0.0028 6.6345 0.0028 0.0000
Z2245 6.2688 0.0037 6.2634 0.0039 0.0002
Z2246 6.0763 0.0043 6.0767 0.0040 0.0003
Z2247 5.6722 0.0060 5.6766 0.0066 0.0006
Re-estimating the Standard Deviation Based on the estimated parameters
a = 0.0103, r = 0.9908 and λ = 0.4751 an analysis dataset is simulated. From
the simulated dataset the parameters a, r, λ are re-estimated. For this purpose,
200 logarithmic intensity pairs are created by generating two normally distributed
random numbers corresponding to intensities between 15 and 4000 before taking
the logarithm. In the used programming language (Java1), generation of normally
distributed random numbers is only possible for the standard normal distribution
N (0, 1). Therefore, a transformation of the random numbers following N (0, 1) to-
wards N (µ, σ2) with σ(µ) = a+re−λµ is necessary. Transformations from N (µ, σ2)
to N (0, 1) are given by
Z =
X − µ
σ
(3.12)
1http://java.sun.com/
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where Z is the transformed value of X which is the N (µ, σ2) distributed measured
value. Consequently, transformation from N (0, 1) to N (µ, σ2) is achieved by
X = Zσ + µ. (3.13)
From these simulated intensity pairs the parameters a, r, λ are re-estimated result-
ing in a = 0.0117, r = 0.9857 and λ = 0.5348. Since these values are similar
to those, used for the generation of the simulated dataset, the proposed model is
empirically consistent.
3.3.4.2 95% Interval
In order to find out whether the trained model and the intensity deviation of
unregulated samples fit together, a so-called 95% interval is determined. The idea
is to calculate the 95% interval for each normally distributed integer logarithmic
intensity as illustrated in Figure 3.8. Finally, 95% of the expression ratios of a
sample should be located inside the interval and 5% outliers are accepted.
Figure 3.8: Standard normal distribution. The values a and b give the borders of the
marginal 2.5% for the calculation of the 95% interval of intensities.
Therefore, the marginal borders a and b with P (a ≤ Z ≤ b) = 0.95 are to be
found. This is carried out by the means of statistical standard algorithms that are
available for the standard normal distribution N (0, 1). Assuming two identically
regulated samples with n pairs of logarithmic intensities (y(1)i , y
(2)
i ), 1 ≤ i ≤ n,
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follows µ(1)i = µ
(2)
i . Subtraction of the means and addition of the variances leads
to
N (µ, σ2) = N (µ(1) − µ(2), (σ(1))2 + (σ(2))2)
= N (0, (a+ re−λµ(1))2 + (a+ re−λµ(2))2)
= N (0, 2(a+ re−λµ)2). (3.14)
The calculated borders are transformed from N (0, 1) to N (µ, σ2) by application
of (3.13). Hence, the borders are x and −x, respectively, with
x = z
√
2(a+ re−λµ)2 (3.15)
where a = 0.0103, r = 0.9908, λ = 0.4751 and µ = the currently regarded logarith-
mic intensity.
The values for 95% interval exclusively depend on the estimated parameters.
Consequently, they are the same for all datasets shown in the following paragraphs.
Training Dataset Positioning of the training dataset that was used for the esti-
mation of the model parameters within the 95% interval serves as proof-of-concept.
Pseudo-expression ratios are calculated by dividing the measured intensities of each
subset by its mean value. Figure 3.9 shows 24 subsets each consisting of 23 in-
dividual intensity measurements. The curves give the 95% interval for normally
distributed noisy intensities with N (0,√2σ2).
Figure 3.9: Logarithms of pseudo-expression ratios from the training dataset within the
95% interval. Each subset of the training dataset represents one intensity, pseudo-expression
ratios are calculated by dividing the measured intensities by the mean value of the intensities
of the corresponding subset.
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Test Dataset The experimental test dataset (Figure 3.10, also compare Figure
3.2) comprises logarithmic expression ratios of 563 peptides. Tryptically peptides
from six different proteins were differentially labelled with iTRAQTM 115.1 or
117.1, mixed in the ratio 1:1 and then analysed by MS. 2.84% of the peptide
regulation factors are located outside the 95% interval – given by the black curves
– which is calculated from the training dataset.
Figure 3.10: Logarithms of expression ratios from the training dataset are plotted against
the logarithmic mean intensity from both differentially labelled subsamples. The black lines
give the 95% interval, 2.85% of the regulation factors are located outside the interval.
Simulation Simulation of a dataset based on the model parameters that were
estimated from the training dataset (Figure 3.11) shows striking similarities to
the intensities detected in the experimental test dataset (Figure 3.10). Every
integer intensity between 1 and 2000 (eµ) was used for the generation of two noisy
intensities (sim1 and sim2) according to the noise model with the parameters
a = 0.0103, r = 0.9908 and µ = 0.4751. Values of ln( sim1
sim2
) are plotted against µ.
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Figure 3.11: Logarithms of expression ratios from a simulated unregulated sample within
the 95% interval. Every integer intensity between 1 and 2000 (eµ) was used for the generation
of two noisy intensities (sim1 and sim2). Values of ln( sim1sim2 ) are plotted against µ.
Complex Sample Tryptically generated peptides from a complex biological sam-
ple were differentially labelled with iTRAQTM 115.1 or 117.1, mixed in the ratio
1:1 and then analysed by MS. 1.9% of the peptide expression ratios are located
outside the 95% interval supporting the conservative and representative character
of the established noise model.
Figure 3.12: Logarithms of expression ratios from an unregulated complex biological sample
are plotted against the logarithmic mean intensity from both differentially labelled subsam-
ples. The black lines give the 95% interval, 1.90% of the regulation factors are located outside
the interval.
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In summary, all made assumptions
(i) log-normally distributed intensities
(ii) σ(µ) = a+ re−λµ
were approved – or at least, could not be rejected – by the applied tests for the
validation of the noise model.
3.3.5 Applications of the Noise Model
Besides the identification of significant regulations by finding the most probable
regulation factor (chapter 4), two applications for robustness analysis of intensities
and regulation could be derived from the noise model.
Error Probability of Contrary Regulation
The error probability of contrary regulation gives the probability that the measure-
ments and the corresponding true intensities are in the same order. For example,
if x1 was measured smaller than x2 the error probability gives the probability that
also the true intensity of x1 is smaller than that of x2. Assuming that eµ1 and eµ2
are the true intensities of x1 and x2, respectively it is supposed that eµ1 ≥ eµ2 , i.e.
the true intensities are not in the same order as the measured intensities. This
happens with probability
2 · P (Yµ2 ≥ ln(x2)) · P (Yµ1 ≤ ln(x1)). (3.16)
The factor 2 reflects that the order (in time) in which x1 and x2 were measured is
not considered. Without the factor 2 the meaning were that the larger value x2 is
measured after the smaller value x1. µ1 and µ2 are to be found with µ2 ≤ µ1 such
that (3.16) is maximised. It is obvious that µ2 should be as large as possible in
order to maximise P (Yµ2 ≥ ln(x2)), whereas µ1 should be as small as possible in
order to maximise P (Yµ1 ≤ ln(x1)). Figure 3.13 shows three examples of choosing
µ1 and µ2 given measurements of x1 and x2. In the upper example µ1 and µ2
have a large distance to each other, in the middle they are nearer and in the last
example µ1 and µ2 are identical. The areas to be maximised corresponding to
P (Yµ2 ≥ ln(x2)) and P (Yµ1 ≤ ln(x1)), respectively, are coloured. Obviously, the
sum of the coloured areas is the highest if µ1 = µ2.
44 3 iTRAQTM -specific Noise Model
Figure 3.13: Three examples of choosing µ1 and µ2 given the measurements x1 and x2. The
areas to be maximised corresponding to P (Yµ2 ≥ ln(x2)) and P (Yµ1 ≤ ln(x1)), respectively,
are coloured. Maximum of the sum of the coloured areas is found if µ1 = µ2.
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With the constraint µ2 ≤ µ1, (3.16) will only achieve its maximum if µ1 = µ2
holds. This means, maximising (3.16) is equivalent to maximise
2 · P (Yµ ≥ ln(x2)) · P (Yµ ≤ ln(x1)). (3.17)
with the parameter µ. (3.17) is equivalent to the objective function
g(µ) = 2 ·
(
1− Φ
(
ln(x2)− µ)
a+ re−λµ
))
· Φ
(
ln(x1)− µ)
a+ re−λµ
)
(3.18)
where Φ is the cumulative distribution function of the standard normal distribu-
tion. This is done again by an evolution strategy with adaptive mutation rates.
The maximum value of g(µ) is the maximum probability that two true intensities
with the reverse order of x1 and x2 can produce values like x1 and x2 but it is not
the probability that the true intensities for x1 and x2 are in the reverse order. The
computed probability, i.e. the maximum value of the function g, is the highest
possible probability that two true intensities eµ1 and eµ2 with µ2 ≤ µ1 can produce
an intensity pair like x1 and x2.
Considering a dataset of statistical inferences simultaneously causes the multiple
comparisons problem. Errors in inference, e.g. hypothesis tests incorrectly rejecting
the null hypothesis, are more likely when the dataset is considered as a whole. In
order to avoid this problem the significance level of the resulting values is adapted
by Bonferroni correction to 1
n
of the significance level of each single comparison
where n is the number of peptides.
Intensity Interval
The intensity interval gives the range of the true intensity corresponding to a
measurement x according to a defined significance level. A value α (e.g. 0.05)
must be specified determining the probability to which it is acceptable that the log-
normal random variable Xµmax for the true intensity eµmax will produce a value less
than or equal to x if eµmax > x holds. eµmax will be the upper bound for x. Similarly,
for the lower bound eµmin < x, α is the probability that the log-normal random
variable Xµmin produces a value larger than or equal to x. Yµmax = ln(Xµmax)
and Yµmin = ln(Xµmin) denote the corresponding normal distributions. Figure 3.14
illustrates this context: Yµmax and Yµmin are able to produce the intensity ln(x)
with certain probabilities. µmax and µmin must be found so that these probabilities
are equal to the specified significance level α.
The probability for the upper bound is given by
α = P (Xµmax ≤ x) = P (Yµmax ≤ ln(x)) = P
(
Z ≤ ln(x)− µmax
a+ re−λµmax
)
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Figure 3.14: Determination of the lower and the upper bound of the intensity interval.
Yµmax and Yµmin are able to produce the intensity ln(x) with certain probabilities. µmax and
µmin must be found so that these probabilities are equal to the specified significance level α.
where Z is the standard normal distribution with mean 0 and variance 1. There-
fore, the equation
Φ
(
ln(x)− µmax
a+ re−λµmax
)
− α = 0 (3.19)
has to be solved for µmax. As in (3.17), Φ is the cumulative distribution function
of the standard normal distribution. This is done again by simple bisection. One
boundary is chosen as ln(x), the other one is determined by searching in the
entourage of ln(x) for a change of the sign of (3.19).
Analogously, for the lower bound is required
α = P (Xµmin ≥ x) = P (Yµmin ≥ ln(x)) = P
(
Z ≥ ln(x)− µmin
a+ re−λµmin
)
leading to
1− Φ
(
ln(x)− µmin
a+ re−λµmin
)
− α = 0 (3.20)
(3.20) is solved by the same strategy as (3.19).
Note that α is not the probability that the true intensity lies in the interval
[eµmin , eµmax ]. It only means that a true intensity outside this range will produce a
value like x with a probability lower than α.
3.3.6 Comparison with Other Approaches
Intensity dependent noise within iTRAQTM data was described in several studies in
the last years. For example, Hu et al. (2006) recommended to discard low-intensity
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spectra and identified the necessity for the incorporation of noise model analysis
with comprehensive statistical robustness as described for microarray analysis.
Recently, Du et al. (2008) published an approach for modelling noise of mass
spectrometry based proteomics. The noise in MS1 is estimated by comparing ex-
pected and observed isotopic patterns based on well-known frequencies of isotopes
of carbon which is assumed to follow a multinomial distribution. Additionally,
for a Q-TOF device an intensity dependent part of the noise is described which
is approximated by a Poisson distribution by the authors. The advantage of a
Poisson based model is the absence of parameters (additionally to the intensity),
hence no parameter estimation is necessary. Application of 95% interval based on
the Poisson distribution to the test dataset shows that intensity dependent noise
of the used Q-TOF device can also be modelled by Poisson (Figure 3.15).
Figure 3.15: Calculation of a Poisson based 95% interval and application to the test dataset.
Intensity dependent noise of iTRAQTM labelled samples analysed on a Q-TOF device alter-
natively can be approximated by a Poisson distribution.
However, using an Orbitrap XL device the observable noise characteristics are
different and consequently, the 95% interval derived from the Poisson model does
not fit the data as shown in Figure 3.16. The usage of a Poisson model for esti-
mating the noise of the Q-TOF device may be beneficial due to lack of training,
otherwise this model also requires the implementation of further parameters. Gen-
erally, the noise should be characterised using a scalable model comprising enough
parameters in order to be applied to different workflows.
3.3.6.1 Alternative Models
In addition to the presented noise model h(µ; a, r, λ) = a + re−λµ further models
were investigated, which also might be able to simulate a representative distribu-
tion of iTRAQTM intensities. Investigation of 563 independent data points from
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Figure 3.16: Calculation of Poisson based 95% interval and application to an unregulated
sample analysed on Orbitrap XL using two different modes (HCD mode and PQD mode).
Intensity dependent noise of iTRAQTM labelled samples analysed on an Orbitrap XL device
can not be approximated by a Poisson distribution.
the test dataset calculates the best approximation regarding the expected 5% ratio
of outliers (95% interval) for the presented model. Therefore, the established noise
model is representative with a minor tendency to define some real regulations as
non-regulated (2.84% instead of 5% outliers).
Table 3.7: Percentage of regulatory outliers (95% interval) calculated by different noise
models and based on the test dataset.
h(µ; θ) outliers [%]
h(µ; a, r, λ) = a+ re−λµ 2.84
h(µ; a, r) = a+ rµ2 30.73
h(µ; a, r) = a+ rµ+1 0.00
h(µ; a, r) = a+ rµ 0.00
3.3.6.2 Bayesian Statistics
Bayesian statistics traces back to Thomas Bayes (1702-1761). The centre of in-
terest is built by Bayes’ theorem allowing to estimate unknown parameters, to
identify confidence intervals as well as hypothesis testing concerning these param-
eters. Traditional statistics considering unknown parameters as constants (instead
of random variables) and determining probabilities by frequencies are not able to
estimate constants not at random.
Bayesian statistics uses prior probabilities giving prior knowledge by a probabil-
ity distribution. Bayes’ theorem defines calculations with conditional probabilities
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and is often used to compute posterior probabilities. Given events A and B Bayes’
theorem is
P (A|B) = P (B|A) · P (A)
P (B)
(3.21)
with
P (A) = prior probability of A
P (A|B) = conditional probability of A, given B (“posterior probability”)
P (B|A) = conditional probability of B given A
P (B) = prior or marginal probability of B.
Bayes’ theorem describes the way in which one’s beliefs about observing A are
updated by having observed B. For example, Bayes’ theorem is applied in medicine
when a test having a defined error probability returns a positive result (“diseased”)
and the probability of the existence of the disease is in demand.
Comparison with Bayesian Approach Baldi and Long (2001) developed a soft-
ware tool (called Cyber-T) for the analysis of microarray expression data2 based
on Bayesian statistics. Cyber-T is a statistical program with a web interface that
can be conveniently used on high-dimensional array data for the identification of
statistically significant differentially expressed genes. It also contains a compu-
tational method for estimating experiment-wide false positive and negative levels
based on the modelling of p-value distributions (PPDE).
In order to compare the established model with a Bayesian approach identical
datasets are introduced to Cyber-T and the presented noise model. However,
Cyber-T expects datasets containing two measurements of each unstimulated and
stimulated samples. Proteomics is not able to comply with this condition since MS
experiments never identify identical peptides and intensity heights are only relative
that can not be compared to each other over several experiments. Therefore, a
simulated dataset was built by generating pairs of unregulated as well as pairs of
regulated noisy intensities according to the presented model. The simulated noisy
intensities corresponding to every of 2000 true, unknown intensities (µ) are at a
defined ratio of c: 80% of the tuples are unregulated (c = 1), each 5% are slightly
regulated in a ratio (c) 1 : 1.25, 1 : 1.5, 1 : 2 and 1 : 3.
2000 4-tuples and 2000 2-tuples (1 x unregulated, 1 x regulated) were introduced
to Cyber-T and the established noise model. Since the dataset based on known
regulations, the identified regulations of both approaches are comparable. Based
on the noise model’s p-values (section 3.3.5) and Cyber-T’s PPDEs the result is as
listed in Table 3.8. The columns refer to the introduced ratio as well as the false
2http://cybert.microarray.ics.uci.edu/
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positive and false negative identified results of Cyber-T and the new established
noise model, respectively.
Table 3.8: Result of the comparison of the presented error probabilities of the established
noise model and the Bayesian approach for the calculation of probabilities for differential ex-
pression (Cyber-T). The columns refer to the introduced ratio as well as the false positive and
false negative identified results of Cyber-T and the new established noise model, respectively.
Ratio Cyber-T Noise Model σ = a+ re−λµ
1 : 1 0% false positive 0.75% false positive
1 : 1.25 73% false negative 62% false negative
1 : 1.5 36% false negative 27% false negative
1 : 2 9% false negative 10% false negative
1 : 3 2% false negative 2% false negative
The outcome clearly shows that the Bayesian approach in Cyber-T has no ad-
vantages concerning the validity of the existence of a regulation compared with the
noise model presented in this work. The percentage of false positive and false neg-
ative results is higher for the Cyber-T software in comparison with the presented
noise model.
4 Identification of Significant
Regulations
In section 2.3 an intuitive method for the calculation of regulation factors at the
level of peptides was introduced by dividing the measured iTRAQTM ion intensities.
However, this idea does not consider the different quality of intensities presented
in the previous section. Furthermore, a concept for the calculation of the most
suitable regulation factor of any group of peptides is necessary. One possible ap-
plication of this approach is the calculation of representative protein regulation
factors based on individual peptide information. Weighted calculation of a regula-
tion factor concerning an individual peptide considering all measurements of this
peptide is required if it was detected several times comprising different regulation
factors or if several MS/MS experiments are merged. Therefore, the calculation of
the average regulation of several peptides and even the calculation of the regulation
of single peptides must be performed in an intensity dependent manner.
Although Boehm et al. (2007) regard intensity dependent noise and take error
estimations into consideration, they provide no strategy for intensity dependent
weighting while calculating peptide and protein expression ratios. Actually, in the
case of a large number of peptides, the median peptide expression ratio is recom-
mended as protein expression ratio. Lin et al. (2006) deal with impreciseness of
regulation factors derived from low intensity signals by simply defining a minimum
intensity threshold. The remaining peptide expression ratios are determined by
dividing iTRAQTM ion intensities whereas the protein expression ratios are derived
from calculating a weighted sum of the peptide expression ratios. The peptides
are weighted corresponding to the percentage of the sum of their iTRAQTM ion
intensities regarding the sum of iTRAQTM ion intensities of all peptides belonging
to one protein. Protein expression ratios calculated according to this approach are
similar to those presented in the following.
As an application of the presented noise model an intuitive concept was devel-
oped for the visualisation-aided exploration of regulatory iTRAQTM data based
on likelihood curves precisely depicting the overall data dependent quality of reg-
ulatory information (Hundertmark et al., 2008). This approach can be applied to
both, the peptide and the protein level: (i) one or more identical peptides resulting
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in peptide likelihood curves and (ii) different peptides of a protein resulting in a
protein likelihood curve as illustrated in figure 4.1.
Figure 4.1: Levels of information: Regulation can be presented on the level of the measure-
ment by calculation of ratios (division of measured intensities) and on the peptide level as
well as on the protein level by calculation of the overall regulatory information.
4.1 Calculation of Regulatory Information
The expression ratio of a single peptide can be simply determined by dividing
the iTRAQTM ion intensities if only one fragmentation experiment (MS/MS) was
generated within an experiment. However, and as discussed in Hu et al. (2006),
a different approach is required if multiple MS/MS spectra match to one peptide
(“one peptide was identified several times”). According to the noise model, expres-
sion ratios derived from high intensities are more representative compared to those
derived from low intensities. Therefore, reporter ion ratios that all have to be cor-
related to the same peptide should be integrated in a weighted manner depending
on their reporter intensities and their corresponding signal qualities. In order to
find the most likely expression ratio for a peptide, all possible expression ratios cj
between the lowest (cmin) and the highest ratio of iTRAQTM ion intensities (cmax)
are discretised before they are related to all MS/MS spectra that match the actual
considered peptide.
For each expression ratio cj and each measured pair of intensities (xi, yi), 1 ≤
i ≤ n, n = number of matched MS/MS spectra, a suitable pair of intensities
is calculated by setting µxi = cjµyi where µxi and µyi are the true, unknown
intensities of the measured intensities xi and yi, respectively. To find the best
expression ratio cj for all n matched MS/MS spectra the likelihood function
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L(x, y, cj) =
n∏
i=1
(
1√
2piσxi
e
−
„
xi−cjµyi
2σxi
«2
1√
2piσyi
e
−
„
yi−µyi
2σyi
«2)
(4.1)
is computed with σx = a+ re−λµx and σy = a+ re−λµy .
Logarithmic transformation and omitting the constant parts lead to the log-
likelihood function
L˜(x, y, cj) =
n∑
i=1
(
− ln(σxi)−
(
xi − cjµyi
2σxi
)2
− ln(σyi)−
(
yi − µyi
2σyi
)2)
. (4.2)
The best suitable overall expression ratio cj for all matched MS/MS spectra of
a multiple found peptide according to the noise model is the ratio resulting in the
maximum log-likelihood according to (4.2).
The calculation of a protein expression ratio takes place in the same manner.
Instead of regarding the expression ratios of a (multiple) matched peptide, the
regulation factor which is best representing all peptides of the observed protein is
computed. This is done by calculating the likelihoods for all regulation factors cj
to be considered (cmin ≤ cj ≤ cmax and a sufficiently small step size for cj) and
choosing the one resulting in the maximum likelihood. Hence, there are
n = total number of all MS/MS spectra matched to the regarded peptide(s)
cmin = lowest expression ratio of a matched MS/MS spectrum
cmax = highest expression ratio of a matched MS/MS spectrum
for the estimation of the expression ratio.
For visualisation purposes (section 4.2) it is important, to have symmetric ranges
of possible regulation factors, i.e. regulations in [0 . . . 1] are transformed to
[−∞ . . .−1] by replacing the measured intensities and adding a negative sign. For
instance, if intensities 100 and 200 are measured corresponding to iTRAQTM labels
115.1 and 117.1, the resulting regulation factor after dividing the intensity of label
115.1 by that of label 117.1 is 1
2
. Transformation is performed by dividing the in-
tensity of label 117.1 by that of label 115.1 and adding a negative sign. Therefore,
the outcome is −200
100
= −2.
Regulation factors of single peptides are calculated this way as well. Conse-
quently, if the intensities are extremely low, the resulting expression ratio is slightly
deviating from the ratio of the intensities since usage of higher intensities results
in a higher maximum likelihood due to decreasing noise at increasing intensity.
Thus, this approach can integrate information of all experimentally observed
results without the necessity to reject data by arbitrary threshold levels. The
quality of each iTRAQTM reporter intensity can be specified by the established
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noise model based on its individual intensity. Low intensity reporters in combina-
tion with those of better signal qualities, i.e. higher intensities, have only a minor
effect on the final result, and vice versa.
An example of the resulting regulation factors calculated according to (4.2) is
given below. 21 identified peptides and corresponding iTRAQTM ion intensities of
the protein GSK3α from HGF stimulated cells in comparison with unstimulated
cells are listed in Table 4.1. Column “Ratio” refers to the ratios obtained by
dividing ion intensities iTRAQTM 115.1 and 117.1, column “MLE Ratio” refers to
the regulation factor calculated according to (4.2). For comparison, the column
“Mean” gives the mean value of the iTRAQTM ion intensity ratios in case the
peptide was matched several times. The calculated protein ratio (MLE) of GSK3α
in this example is −1.26 (not listed in Table 4.1).
Table 4.1: Peptides of GSK3α from HGF stimulated cells in comparison with unstimulated
cells (Hundertmark et al., 2008). Columns refer to peptide sequence, iTRAQTM 115.1 ion
intensity, iTRAQTM 117.1 ion intensity, ratio obtained by dividing iTRAQTM 117.1 ion in-
tensity and iTRAQTM 115.1 ion intensity, MLE regulation factor according to (4.2) and the
mean value of iTRAQTM ion intensity ratios (only if a peptide was matched several times).
Phosphorylated amino acids are coloured.
Peptide sequence iTRAQTM 115.1 iTRAQTM 117.1 Ratio MLE Ratio Mean
YFFYSSGEK 215.87 212.66 -1.02 -1.18 -1.20
YFFYSSGEK 693.28 500.58 -1.38 -1.18 -1.20
GEPNVSYICSR 3969.56 3073.30 -1.29 -1.29
SQEVAYTDIK 6415.65 3593.18 -1.79 -1.78
GEPNVSYICSR 4393.51 3302.95 -1.33 -1.33
GEPNVSYICSR 1770.04 1396.09 -1.27 -1.27
VTTVVATLGQGPER 2677.79 2324.79 -1.15 -1.15
GEPNVSYICSR 512.76 489.10 -1.05 -1.05
VIGNGSFGVVYQAR 9501.10 7655.79 -1.24 -1.24
SLAYIHSQGVCHR 1341.66 1128.88 -1.19 -1.19
DIKPQNLLVDPDTAVLK 23.29 16.46 -1.41 -1.15 -1.46
DIKPQNLLVDPDTAVLK 466.03 381.36 -1.22 -1.15 -1.46
DIKPQNLLVDPDTAVLK 10.27 6.05 -1.70 -1.15 -1.46
DIKPQNLLVDPDTAVLK 460.73 419.40 -1.10 -1.15 -1.46
DIKPQNLLVDPDTAVLK 87.00 105.39 1.21 -1.15 -1.46
DIKPQNLLVDPDTAVLK 37.81 23.89 -1.58 -1.15 -1.46
DIKPQNLLVDPDTAVLK 56.18 34.64 -1.62 -1.15 -1.46
DIKPQNLLVDPDTAVLK 18.64 10.25 -1.82 -1.15 -1.46
TPPEAIALCSSLLEYTPSSR 4.70 2.17 -2.17 -1.42
TSSFAEPG...GGGK 405.13 1289.34 3.18 3.15 3.16
TSSFAEPG...GGGK 220.62 690.21 3.13 3.15 3.16
As illustrated in Table 4.1, the peptide DIKPQNLLVDPDTAVLK was identified eight
times revealing iTRAQTM reporter ion intensities between 2.17 and 466.03 and
expression ratios (derived by division) between −1.82 and −1.10. The MLE cal-
culated regulation factor on the one hand is −1.15, the mean value of the MLE
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calculated peptide ratios on the other hand is −1.46. Calculation of MLE ratio is
weighted in favour of high intensity measurements. Consequently, the impact of
the last entry of DIKPQNLLVDPDTAVLK referring to iTRAQTM ion intensities 18.64
and 10.25 and a resulting expression ratio −1.82 is low. However, the impact of
the measurements of the ion intensities 466.03 and 381.36 as well as 460.73 and
419.40 resulting in ratios −1.22 and −1.10, respectively, is high. Actually, the
MLE ratio is calculated as −1.15 which is very close to −1.22 and −1.10.
The MLE ratio of the peptide TPPEAIALCSSLLEYTPSSR strongly deviates from
the ratio determined by dividing the ion intensities (−1.42 instead of −2.17). The
reason is mentioned before: due to increasing deviations in decreasing intensity
ranges the very low signal intensities (4.70 and 2.17) result in lower likelihoods
than slightly changed signal intensities.
4.2 Visualisation of Regulatory Information
All likelihood values lj are plotted against the corresponding expression ratios cj
using the Java chart library JFreeChart1. Due to area normalising (
∫ cmax
cmin
= 1) the
robustness of the underlying data is proportional to both the height and the slope
of the produced curves which are called “likelihood curves” in the following. A
likelihood curve represents the likelihoods (y-axis) of the most probable regulation
factor – given by the maximum likelihood – as well as alternative regulation factors
(x-axis). Therefore, the range of regulations is strongly limited within narrow
curves in contrast to plain curves providing a wide range of regulations. In addition
to the visual presentation, the information on robustness of the underlying data is
given by the interval of robustness (IR) comprising the minimum interval length
which contains 80% of the area under the corresponding curve. According to the
range of possible regulation factors the range [−1 · · ·+ 1] is omitted.
Figure 4.2 shows the peptide likelihood plot of the protein GSK3α. Each peptide
is represented by a separate likelihood curve. The 80% IR is given in the right
top side of the plot. Most of the regulatory information is very robust, reflected
in IR values near 0.2. However, the reliability of the regulatory information on
the peptide TPPEAIALCSSLLEYTPSSR (intensities 4.70 and 2.17) is of lowest quality
since the probability of all regulation factors between −3.5 and 1 is nearly identical,
resulting in an IR value of 4.25.
1http://www.jfree.org/jfreechart/
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Figure 4.2: Peptide likelihood plot of the protein GSK3α from HGF stimulated cells. Each
peptide is represented by a separate likelihood curve. Most of the peptides are slightly
downregulated, one peptide is significantly downregulated and another one is significantly
upregulated. The flat curve refers to a peptide of lowest signal intensities. Legends at the
bottom and the right top side of the plot refer to the displayed peptide sequences and intervals
of robustness (IR), respectively.
Depending on the aim of the analysis various views of a protein may be useful.
All peptides of the protein can alternatively be represented separately by individual
curves (peptide view) or be combined and visualised by a shared curve (protein
view) within the plot. While Figure 4.2 shows the peptide view of GSK3α, Figure
4.3 illustrates the protein view of the same protein where a single likelihood curve
represents the total protein. Finally, both kinds of information can be combined
in such a way that individual peptides can be plotted separately in contrast to the
remaining peptides of the protein (e.g. modified and unmodified peptides). Figure
4.4 illustrates this by presenting single curves corresponding to phosphopeptides
and a shared protein curve (red) giving the unphosphorylated peptides. Omitting
the modified peptides for the calculation of the protein curve results in a marginal
shift of the curve towards a heavier downregulation.
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Figure 4.3: Protein likelihood plot of the protein GSK3α. All peptides are represented by
a shared likelihood curve. Since most of the peptides are regulated very similar (compare
Figure 4.2) the resulting protein curve is extremely narrow (80% IR = 0.06).
Figure 4.4: Mixed likelihood plot of the protein GSK3α. Each phosphopeptide is repre-
sented by a separate likelihood curve, non-phosphopeptides are represented by the red curve.
Legends at the bottom and the right top side of the plot refer to the displayed peptide
sequences and intervals of robustness (IR), respectively.
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4.3 Development of the iTRAQassist Web
Application
The strategies presented for the calculation and visualisation of regulatory infor-
mation have been implemented as a web-based service for in-house analyses called
“iTRAQassist”. The program workflow includes preprocessing as described in sec-
tion 3.1 performing improved peak detection, correction of isotopic impurities,
sample normalisation and logarithmic transformation. Afterwards, the calculation
of intensity intervals and error probabilities of contrary regulation (section 3.3.5)
is performed before computing and visualising the regulatory information. Since
large experiments result in very long program run times and need lots of memory
for the calculations the application was developed as a web application in order
to avoid blockages of desktop computers. The usage of Java for programming
the calculations requires Apache Tomcat2 (V5.5) and Java Servlet as well as Java
Server Page technologies.
The iTRAQassist webinterface (Figure 4.5) allows to choose between different
program settings, e.g. consideration of peptide phosphorylation, preferring peptide
or protein view, definition of an enlarged mass range for peak detection as well
as discarding low identified peptides (Mascot Peptide Score). Besides specifying
the applied iTRAQTM reagents, essential information concerning the files contain-
ing the experimental results (Mascot .dat file) and the measurements of isotopic
impurities (containing comma separated values) must be entered by the user.
2http://tomcat.apache.org/
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Figure 4.5: Detail of the iTRAQassist webinterface requiring several settings, e.g. uploading
the experimental result file, selecting a result from the measurements of isotopic impurities
and specification of applied iTRAQTM reagents.
Program run time strongly depends on the number of peptides detected in the
MS experiments whereas the calculation of the likelihoods for possible regulation
factors requires most of the time. Large result files comprising > 1000 peptides
often result in program run times > 30 minutes (Intel Pentium D, 3.2 GHz (Dual
Core), 2 GB RAM). The results consist of two parts: likelihood plots are available
within the HTML result file as well as an additional archive. Furthermore, a result
file can be downloaded (Excel format) containing all available information (peptide
sequences, raw and corrected ion intensities, intensity interval, error probabilities,
most suitable protein as well as peptide regulation factors, normalisation factor,
etc). Figure 4.6 shows an extract of the result of running iTRAQassist.
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Figure 4.6: Result of running iTRAQassist: Information on the experimental file, isotopic
impurities, normalisation factor, the applied iTRAQTM reagents and several settings defined
by the user followed by the link for result file generation (Excel format), and the presentation
of the likelihood plots.
A variation of the iTRAQassist software was developed for the calculation of reg-
ulation factors across several experiments (May (2007)). Preprocessed iTRAQTM
ion intensities of identic peptides from iTRAQassist result files (Excel format) of
different experiments are introduced in the calculation of the most suitable and
alternative regulation factors according to (4.2). Again, the result of the regula-
tion analysis of multiple experiments are likelihood plots and a result file (Excel
format) similar to the result file of the single experiment analysis presented before.
Figure 4.7 shows an extract of the webinterface for analysing the regulatory in-
formation of several experiments by the iTRAQassist software. The iTRAQassist
result files are introduced containing all necessary information unless the mapping
of the used iTRAQTM labels and the experimental conditions.
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Figure 4.7: Detail of the webinterface for analysing the regulatory information of multiple
experiments by iTRAQassist software. Besides iTRAQassist result files from single exper-
iment analysis the mapping of used iTRAQTM labels and the experimental conditions are
required.
5 Detection of Post-translational
Modifications
Figure 4.4 from section 4.2 demonstrates the ability of likelihood plots to relate
regulatory information on specific peptides on the one hand and the remaining
peptides of the same protein on the other hand. Regulatory information on the
remaining peptides is represented either by a combined curve or by individual
peptide curves. Both approaches are basically suitable for comparing the regula-
tory information on specific peptides and the remaining peptides within the same
protein. Mostly, varieties concerning the regulatory information on all peptides
belonging to one protein is low, however, in the case of post-translational modified
peptides regulatory information may differ significantly. Besides the possibility of
false-positive peptide to protein assignments and errors in measurements the ex-
istence of modifications is the most frequent cause for wide differences concerning
the regulatory information on peptides within the same protein.
5.1 Detection of Post-translational Modifications
by Mass Spectrometry
Peptide sequencing by mass spectrometry is based on mass differences of the de-
tected ions (for details see section 2.2.2). Modifications that change the mass of an
amino acid (for example by adding functional groups e.g. phosphate groups) can
result in failure of peptide sequencing if the corresponding mass delta is not con-
sidered as a variable modification. Because of the high variety (> 200) of known
post-translational modifications consideration of all potential PTM in parallel is
not possible due to combinatorial and computational complexity. Therefore, only
those modifications are identified by mass spectrometry that the analysis is opti-
mised for.
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5.2 Peptide Likelihood Curves for the
Identification of PTM
As mentioned before, modified peptides may be regulated significantly within a
differently regulated protein. Those peptides are named “outliers” in the follow-
ing. In several studies, unmodified peptides corresponding to oppositely regulated
modified peptides can be detected. This observation is not surprising since the
proportion of an unmodified peptide which is equivalently present in two samples
decreases if a significant amount of the peptide is modified. Figure 5.1 illustrates
this behaviour. Sample 1 and sample 2 contain equal amounts of the peptide
SSTVTEAPIAVVTSR. After stimulation (sample 2) half of the unmodified present
peptide is phosphorylated. The resulting regulation factors (RF) are 4
1
= 4 in the
case of the phosphopeptide and 3
6
= 1
2
=ˆ− 2 in the case of the unmodified peptide.
Sample 1 Sample 2
SS∼TVTEAPIAVVTSR SS∼TVTEAPIAVVTSR
SSTVTEAPIAVVTSR SS∼TVTEAPIAVVTSR
SSTVTEAPIAVVTSR SS∼TVTEAPIAVVTSR
SSTVTEAPIAVVTSR SS∼TVTEAPIAVVTSR
SSTVTEAPIAVVTSR SSTVTEAPIAVVTSR
SSTVTEAPIAVVTSR SSTVTEAPIAVVTSR
SSTVTEAPIAVVTSR SSTVTEAPIAVVTSR
Figure 5.1: Opposite regulation of the corresponding unmodified peptide if it is modified
resulting in regulation in one of two samples. The resulting regulation factor of the modified
peptide is 4 and that of the unmodified peptide is −2.
Figure 5.2 illustrates a very clear example of a protein containing both upreg-
ulated phosphopeptides (modified at two neigbouring amino acids) and the cor-
responding downregulated unmodified peptide. The upregulated phosphopeptides
are represented by the green (RF = 4.66), purple (RF = 4.52) and grey (RF =
19.03) curves, the corresponding unmodified peptide (turquoise) is downregulated
(RF = −5.96).
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Figure 5.2: Likelihood plot of the protein MK01 containing one differently phosphorylated
upregulated peptide (green, purple, grey) and the corresponding downregulated unmodified
peptide (turquoise).
The example above shows the opposite expression of modified and unmodified
variants of one peptide within the same protein. Depending on the existing quan-
tities of modified and unmodified peptides, this relation can be more or less pro-
nounced – in many cases the expression of the unmodified peptide is not changed
at all due to low abundance of modified peptide. However, if the correspond-
ing unmodified peptide is regulated diffferently than the remaining unmodified
peptides of a protein, then this could be a starting point for the investigation of
post-translational modifications.
A promising new approach for the detection of such outlying peptides concern-
ing their regulatory information is cluster analysis of peptide likelihood curves
belonging to the same protein. In the case of discovering a single peptide which
is significantly regulated differentially within a protein and fulfilling some further
conditions (for details see section 5.2.1), this peptide could be the target of a
known or unknown modification. Unfortunately, the existence of a modification
is not the only possible cause for the observed behaviour, expression regulation of
protein isoforms could induce a similar effect. A protein isoform is a version of a
protein with only small differences in sequence and function to another version of
the same protein. Different forms of a protein may be produced from different but
related genes, or may arise from the same gene by alternative splicing which is a
method to exchange the sequence of gene products. Partial protein degradation
by cellular enzymes (so called “proteolysis”) which is a PTM as well and protein
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isoforms may yield similar results: In both cases, the regarded peptide may be
detected more frequently – even exclusively – in one of the samples.
From these considerations a strategy for the detection of outliers can be derived
that returns a list of potential modified peptides.
5.2.1 Strategy for the Detection of PTM
First of all, analysis of the regulatory information is performed according to the
established noise model resulting in peptide likelihood curves. In order to allow
the identification of outliers a minimum number of four peptides must be assigned
to every further considered protein. The identification of outlying peptides is not
possible if the minimum number of peptides is lacking that the outlier is related
to. Proteins have to be analysed by a clustering approach which returns clusters of
peptides concerning their regulatory information. Every single peptide forming its
own cluster – in the following called “single cluster peptide” – is considered to be
a regulatory outlier and consequently, might represent a PTM regulated protein
region.
If this strategy suggests one peptide as an outlier, using EBI’s webservice client
WSDbFetch1 known modifications are queried from UniProtKB database2 corre-
sponding to each remaining single cluster peptide. This draft of a workflow forms
a first basis for screening large datasets for unknown modified peptides. Upon
introducing general clustering approaches and comparison of several specific clus-
tering algorithms adapted to the existing data, first results are given in section
5.3.3.3. Analysis of protein isoforms and peptide to protein assignments are not
included.
5.3 Cluster Analysis
Cluster analysis (clustering) is the process of grouping data into classes or clusters
so that objects within a cluster have high similarity to each other in comparison to
objects that belong to different clusters. By the means of cluster analysis patterns
within datasets are to be found. Cluster analysis is an unsupervised learning
technique. This means that the classification of the objects is performed without
knowledge about the available classes. Similarities and dissimilarities of the object
are based on attribute values describing the data. Often, distance measures are
used for the characterisation of (dis)similarities.
1http://www.ebi.ac.uk/Tools/webservices/downloads/java/lib.zip, 11.08.2008
2http://expasy.org/sprot/, 11.08.2008
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5.3.1 Introduction into Cluster Analysis
Most of the clustering techniques are either hierarchical or partitioning clustering
algorithms. Hierarchical algorithms create a hierarchical decomposition of the
given set of data objects. They can be agglomerative (“bottom-up”) or divisive
(“top-down”). Agglomerative algorithms start with clusters each containing one
element and continue merging the clusters. Divisive algorithms start with one
large cluster containing all elements in the dataset and continue splitting clusters.
Hierarchical clustering generates data in a tree structure which is illustrated by
dendrograms in general. Partitioning algorithms on the other hand construct a
partition consisting of k subsets of the data where each subset represents a cluster.
The most known representatives of partitioning clustering algorithms are k-means
and its derivatives. k-means starts with randomly generating k clusters. In the
next step, the cluster centres are determined and afterwards each point is assigned
to the nearest cluster centre. Subsequently, the new cluster centres are recomputed.
The previous steps are repeated until some convergence criterion is met. Further
details can be found in A.L. Symeonidis (2005), J. Han (2001) and Guojun et al.
(2007).
Within partitioning clustering, a distinction is drawn between deterministic clus-
tering (“crisp clustering” or “hard clustering”) and probabilistic clustering (“fuzzy
clustering” or “soft clustering”). In contrast to deterministic clustering which as-
signs every object to exactly one cluster (membership degree u of object i and
cluster j; uij ∈ {0, 1}) fuzzy clustering enables objects to belong to one or more
clusters with membership degrees. In the case of membership = 1 and membership
= 0 the object is assigned to the cluster either completely or not at all. The most
common fuzzy clustering algorithm is fuzzy c-means which combines k-means and
the fuzzy principle providing membership degrees between 0 and 1 (membership
degree u of object j and cluster i; uij ∈ [0, 1]).
By means of a distance (similarity) measure the distance (similarity) of two
elements can be determined. Since clusters are represented by objects, which are of
the same structure as the elements to be clustered, distance and similarity measures
are also used for comparisons of elements and clusters as well as comparisons
between clusters. Anytime a cluster is updated the distances between the updated
cluster and the remaining elements and clusters are to be refreshed as well. Some
of the most popular methods for the calculation of the distances between two
clusters A and B are “single linkage”
min{ d(a, b) : a ∈ A, b ∈ B } (5.1)
and “complete linkage”
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max{ d(a, b) : a ∈ A, b ∈ B } (5.2)
with d(a, b) = distance between elements a and b.
5.3.2 Fuzzy Clustering
Fuzzy clustering (probabilistic clustering) divides a dataset into a set of clusters
and – in contrast to hard or deterministic clustering – a data object can be as-
signed to more than one cluster. In order to handle noisy and ambiguous data,
membership degrees of the data to the clusters are computed. Most fuzzy cluster-
ing techniques are designed to optimise an objective function with constraints. The
most common approach is the so-called probabilistic clustering with the objective
function
f =
c∑
i=1
n∑
j=1
umijdij (5.3)
under the constraints
c∑
i=1
uij = 1 for all j = 1, . . . , n (n = number of objects). (5.4)
In this equation it is assumed that the number of clusters c is fixed. How to
determine the number of clusters will be discussed later on in section 5.3.2.3. uij
is the membership degree of the data object j to the ith cluster which depends
on the distance of the object j and the cluster i. dij is a certain distance mea-
sure specifying the distance between data object j and cluster i, for instance the
(squared) Euclidean distance of j to the ith cluster centre if the data objects are
simple points, not likelihood curves as in the case of the investigations here. The
parameter m > 1, called fuzzifier, controls how much clusters may overlap. The
constraints (5.4) lead to the name probabilistic clustering, since in this case the
membership degree uij can also be interpreted as the probability that j belongs
to cluster i. The parameters to be optimised are the membership degrees uij and
the cluster parameters which are hidden in the distances dij. Since this is a non-
linear optimisation problem, the most common approach to minimise the objective
function (5.3) is to alternatingly optimise either the membership degrees or the
cluster parameters while considering the other parameter set as fixed. Assuming
the cluster parameters and therefore the values dij as fixed, the best choice for the
membership degrees is given by
uij =
1∑c
k=1
(
dij
dkj
) 1
m−1
. (5.5)
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If the object j is identical to one or more clusters (dij = 0 for one or more clusters),
one must deviate from (5.5) and assign the object j with membership degree 1 to
one of these clusters and set uij = 0 for the other clusters i.
The update equation for the cluster parameters or prototypes representing a clus-
ter strongly depends on the type of the cluster. For the specific case of likelihood
curves an algorithm is proposed in section 5.3.2.1.
Cluster validity measures are used to validate a clustering result in general and
also to determine the number of clusters. In order to fulfil the latter task, the
clustering might be carried out with different numbers of clusters and that one
yielding the best value of the validity measure (which depends on the selected
measure) is assumed to have the correct number of clusters.
A straight forward validity measure is the objective function (5.3) itself. How-
ever, (5.3) will always decrease with increasing number of clusters. Therefore, if
the number of clusters is determined based on (5.3), the procedure is as follows.
The number of clusters c is increased step by step starting from c = 1 and (5.3)
is evaluated each time. As long as increasing the number of clusters leads to a
significant decrease of (5.3), the optimum number of clusters is still not reached.
Once (5.3) starts to drop slowly when c is increased, c is too high. A challenging
task is to determine the last significant decrease which gives the correct number
of clusters.
There are other validity measures like the partition coefficient and the partition
entropy (Bezdek, 1981). Both these measures validate the clustering result based
on the membership degrees only without taking specific properties of the cluster
prototypes into account.
The partition coefficient is defined by∑c
i=1
∑n
j=1 u
2
ij
n
. (5.6)
The higher the value of the partition coefficient, the better the clustering result.
The highest value 1 is obtained, when the fuzzy partition is actually crisp, i.e.
uij ∈ {0, 1}. The lowest value 1/c is reached, when all data are assigned to all
clusters with the same membership degree 1/c. This means that a fuzzy clustering
result is considered to be better, when it is more crisp.
The partition entropy is given by
−
∑c
i=1
∑n
j=1 uij ln(uij)
n
(5.7)
The lower the value of the partition entropy, the better the clustering result.
This means that similar to the partition coefficient crisper fuzzy partitions are
considered to be better.
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As mentioned before, there are many other validity measures for fuzzy clustering.
However, they are not of interest here, since they assume the data to be points in
Rp and not likelihood curves as in this case.
5.3.2.1 Prototype Based Fuzzy Clustering of Likelihood Curves
Clustering of curves requires the definition of a distance measure which is consider-
ably more complex than comparing the positions of points in a coordinate system.
Various kinds of distance measures for clustering likelihood curves can be imag-
ined e.g. (i) the maximum peak position, (ii) the profile (width and height) of the
curve or (iii) the overlapping area below compared curves. The selected distance
measure serves for comparisons between each curve object and a cluster which is
represented by a protoype curve. The prototype curve has the same properties
as peptide likelihood curves (e.g. total area under the curve = 1) and consists of
those area parts that are shared by the majority of assigned curves (for details see
paragraph “Generation of Prototypes”).
Since likelihood curves give the distribution for the true (unknown) position of
the regulation factor, it would not be advisable to take this value exclusively as
distance measure. Choosing the non-overlapping area of curves as distance measure
combines the position of the regulation factor on the one hand and the profile of
the curve on the other hand. Furthermore, possible uncertainty concerning the
exact position of the regulation factor is taken into account.
It is assumed that the horizontal axis is divided into T intervals of equal length.
Thus, the objective function is (5.3) and dij is given by
1−
∫ +∞
−∞
min{yj(t), vi(t)}dt (5.8)
with yj = peptide j, vi = prototype i.
Discretisation leads to
dij = 1−
T∑
k=1
min{yj(tk), vi(tk)} (5.9)
where t0, . . . , tT are the discretised regulation factors.
Areas under curves are normalised to 1, in consequence 0 ≤ dij ≤ 1 and especially
dij =
{
0 if peptide i and prototype j do overlap completely
1 if peptide i and prototype j do not overlap.
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Minimisation of the objective function f given by (5.3) is done by generation
of new prototype curves from the former prototype curves and the total amount
of peptide curves (for details see section 5.3.2.1). This process terminates when
updating the prototypes yields no further decrease of f .
Generation of Prototypes For the identification of the best partition of all pep-
tide curves into c clusters (c fixed) c prototypes are initialised firstly. Subsequently,
for all prototypes i ∈ [1 . . . c] and all peptides j ∈ [1 . . . n] the membership degrees
uij are calculated by (5.5). The initialisation and update scheme for the cluster
prototypes is described in detail in the following.
The listing below gives a general idea of the algorithm.
result[];
for ( 1 ≤ c ≤ n ){
f(pold) = ∞;
p := initialise prototypes (curves, c);
d := calculate distances (curves, p);
u := calculate u (d);
f(p) := evaluate cluster (u, d);
while ( |f(p) − f(pold)| >  ){
pold := p;
f(pold) := f(p);
p := update prototypes (p, curves, u);
d := calculate distances (curves, p);
u := calculate u (d);
f(p) := evaluate cluster (u, d);
}
result[c-1] = pold;
}
return result;
Initialisation In order to avoid unsuitable results based on an unfavourable ini-
tialisation step, repeated initialisation (number of repetitions k = 3) is preferred.
Initialisation of c prototypes is done by randomly choosing c likelihood curves
from the dataset which are slightly modified by multiplying the centre with a fixed
factor and cutting off the edges when the size of the area A = 1 is reached. To
obtain results as different as possible it is important that different combinations
of peptide curves are selected in all of the k initialisation steps.
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Updating The aim of repeated updating is the generation of a new set of pro-
totypes from the previous set of prototypes. In the case of crisp clustering which
means that the likelihood curve lj either belongs to the cluster i (uij = 1) or not
(uij = 0), the update procedure would be very simple: the more curves are over-
lapping at a position t, the more the objective function for the clustering will be
reduced when the prototype curve has a high value at t as well. At first, areas
with a high number of overlapping curves are added to the prototype. Step by
step, less overlapping areas are added as well and the procedure is finished when
the area below the prototype likelihood curve reaches the value 1. Therefore, the
new prototype likelihood curve is composed of those areas where the majority of
likelihood curves do overlap.
However, fuzzy clustering allows a likelihood curve, that does not match one of
the available clusters perfectly, to be assigned to several clusters. Consequently,
this curve influences marginally several clusters instead of deforming one single
cluster which is a criterion for using fuzzy clustering. Furthermore, fuzzy clustering
provides a number of validity measures for the identification of the number of
clusters inherent in the data. Due to these benefits, fuzzy clustering is applied.
Besides the number of overlapping curves the weight wi
w
(t)
i =
n∑
j=1
umij
(t) (5.10)
strongly affects the development of a prototype i from likelihood curves lj and the
former prototype.
The update procedure for the actual prototype i is as follows: Initially, all points
p
(t)
j that are part of the likelihood curve j, 0 ≤ j ≤ n, are weighted by application of
equation (5.10) related to the considered prototype i. Therefore, points belonging
to a likelihood curve which is similar to prototype i (high membership degree uij),
get better values than those belonging to a curve that is less overlapping with
prototype i. Furthermore, the weight is increasing with every additional curve
which overlaps with curve j in the considered interval.
A simple heuristic strategy to add the most interesting points to the new proto-
type is the following: All of the points are sorted in decreasing order with respect
to their weights, regardless of their belonging to a special peptide curve. Step by
step, the points with the highest weights are added to the prototype likelihood
curve. In order to avoid that two clusters are represented by the same prototype
comprising two centres, every newly added point must be directly adjacent to the
present dataset. This means that the x-coordinate of the new point xp must not
exceed the borders of the interval of the partially constructed likelihood curve
[xmin, ..., xmax] for more than one interval length l (xmin − l ≤ xp ≤ xmax + l).
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Figure 5.3 presents the resulting prototype after initialisation with the labelled
curve and all possible updates. In this example, it is assumed that all six peptides
build a single cluster (c = 1) and the prototype representing this cluster was
calculated.
Figure 5.3: Protein PCTK1: Resulting prototype after initialisation with the labelled curve
and all possible updates. The prototype likelihood curve mainly consists of those areas where
most of the data likelihood curves overlap.
5.3.2.2 Results of Prototype Based Fuzzy Clustering
For identifying the optimal number of clusters the available validity measures “par-
tition entropy”, “partition coefficient” and “objective function” are analysed and the
best assignment of peptide curves has to be found for this number of clusters.
Analysis of Validity Measures
In order to find out how the validity measures could be used for the identification of
the right number of clusters, a plot of the function corresponding to every validity
measure is generated. The results of the functions are plotted over the number of
clusters.
Partition Coefficient The partition coefficient (for details see section 5.3.2 and
(5.6)) should be maximsed at the optimum number of clusters copt. In the case of
c = 1, the partition coefficient is always 1 since every element is assigned to the
only existing cluster with membership degree uij = 1 (compare (5.7)). In the case
of c = n the partition coefficient has a very high value as well. Between these local
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maxima, at least one minimum and a varying number of local maxima may occur.
In general, the maximum value of c, 1 < c < n, is of interest.
The peptide likelihood curves of a protein without differentially regulated pep-
tides – which is the most common case – consist of only one cluster. Consequently,
a maximum at c > 1 does not represent the optimum number of clusters. There-
fore, the optimum number of clusters has to be determined by another mean which
is the detection of the most significant increase after leaving a minimum. If all
peptide curves are assigned to one cluster, the partition coefficient drops down
from c = 1 to c = 2 and increases from then on.
Partition Entropy The behaviour of the partition entropy is directly opposed
to the partition coefficient. According to (5.7) it always starts with 0 in the case
of copt = 1 due to membership degrees uij = 1 and multiplying by lnuij. With
increasing number of clusters, the partition entropy is decreasing. The best number
of clusters is given by the beginning of the decrease after leaving the maximum.
Objective Function The objective function is minimised. An increasing number
of clusters results in a deacrease of the objective function. In order to illustrate this
it is assumed, that n likelihood curves are assigned to c clusters. Addition of a fur-
ther cluster causes that (at least) one curve is assigned to the new cluster yielding
an improved (lower) distance value. The multiplicative impact of the decreasing
distance value results in a deacrease of the objective function. By application of
the so-called “elbow criterion” the corresponding function plot is analysed. The
elbow criterion states that the optimal number of clusters is found as soon as
adding another cluster adds no further significant information. Unfortunately, the
increase from c = 1 to c = 2 is very strong in all cases. Hence, the validation of
only one cluster is not possible.
Examples
In the following, two examples are presented in order to illustrate the analysis of
validity measures and the results of fuzzy clustering. In each case, the topmost
figure depicts the likelihood plot, in the middle are shown the function plots refer-
ring to the partition coefficient (left hand side) and to the partition entropy (right
hand side). The plot of the objective function is placed at the bottom.
The first example shows the protein NEK9. In the peptide plot, 17 peptide
likelihood curves are presented which cluster into more than four clusters. The
analysis of the partition coefficient’s plot (Figure 5.4 middle, left hand side) results
proposing five or seven clusters, since the increases after the corresponding local
minima are strongest. The plot of the partition entropy (Figure 5.4 middle, right
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hand side) suggests to choose seven clusters, since the decrease after the corre-
sponding local maximum is strongest, while the objective function (bottom) yields
copt = 5. The assignment of the peptides by prototype based fuzzy clustering to
five and seven clusters is presented in Table 5.1.
In conclusion, due to different cluster numbers this result is not satisfying.
For example, by visual inspection the phosphopeptides SSTVT∼EAPIAVVTSR and
SST∼VTEAPIAVVTSR are obviously well separated and each must build single-peptide
clusters. The presented prototype based fuzzy clustering approach assigned both
peptides into one common cluster in both possible results (copt = 5 and copt = 7).
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Figure 5.4: Fuzzy clustering results: Likelihood plot and validity measures of the protein
NEK9. Top: Likelihood plot presenting 17 peptides clustering into ≥ 5 clusters. Middle:
Function plot of the partition coefficient (left) and the partition entropy (right) indicating
the existence of 5 or 7 clusters. Bottom: Plot of the objective function indicating the existence
of 5 clusters.
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Table 5.1: Assignment of peptides from Figure 5.4 to 5 and 7 clusters resulting from
prototype based fuzzy clustering.
5 Cluster 7 Cluster
SSTVTEAPIAVVTSR SSTVTEAPIAVVTSR
SSTVT∼EAPIAVVTSR, SST∼VTEAPIAVVTSR SSTVT∼EAPIAVVTSR, SST∼VTEAPIAVVTSR
LGINLLGGPLGGK, LLTFGCNK, QLSFYK, LQGLVLK, VASEAPLEHKPQVEASSPR
TFDATNPLNLCVK, TLNIFLTK
GAFGEATLYR, LGDYGLAK, LQGLVLK, GAFGEATLYR, LGDYGLAK, VLACGLNEFNK
VASEAPLEHKPQVEASSPR, VLACGLNEFNK
AGGGAAEQEELHYIPIR, S∼STVTEAPIAVVTSR, AGGGAAEQEELHYIPIR,
VASEAPLEHKPQVEASS∼PR, VTLLNAPTK VASEAPLEHKPQVEASS∼PR
LGINLLGGPLGGK, LLTFGCNK,
QLSFYK, TFDATNPLNLCVK, TLNIFLTK
S∼STVTEAPIAVVTSR, VTLLNAPTK
The second example shows the protein CDK2. The analysis of the function plot
of the partition coefficient’s(Figure 5.5 middle, left hand side) results in proposing
two clusters. Indeed, the discrepancies of the second, third and the fourth point are
marginal. Hence, the probability for the existence of one, two and three clusters is
nearly the same. Interpretation of the partition entropy (Figure 5.5 middle, right
hand side) is difficult as three clusters seem to be valid, but four clusters could be
possible as well. Subjective analysis of the plot of the objective function results in
copt = 4, since this is the last significant decrease.
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Figure 5.5: Fuzzy clustering results: Likelihood plot and validity measures of the protein
CDK2. Top: Likelihood plot presenting 8 peptides clustering into 2 or 3 clusters. Middle:
Function plot of the partition coefficient (left) and the partition entropy (right) indicate
the existence of 2 and 3 clusters, respectively. Bottom: Objective function indicating the
existence of 4 clusters.
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Since the visual evaluation of validity measure plots turns out to be difficult and
the results are often ambiguous, it is assumed that automatic evaluation will be
difficult. Furthermore, none of the measures provides reliable results at all times
and identification of proteins consisting of one cluster is not possible.
5.3.2.3 Identifying the Number of Clusters
Using the validity measures partition coefficient, partition entropy and objective
function the prototype based fuzzy clustering approach does not lead to satisfying
partitions of peptide likelihood curves. Therefore, other approaches for identifying
the optimal number of clusters are compared in the following. Once the best fitting
number is known, fuzzy clustering may find out the best partition afterwards.
Removing the most distant curves subsequently
This approach is based on the generation of a prototype for all regarded peptide
likelihood curves and subsequently removing the most distant peptide curve in
terms of the prototype curve. In this way the set of likelihood curves is reduced
step by step and the distances of the removed curves are plotted as a plot. Analysis
of entries within the plot returns the result whether there is only one cluster or
not.
First of all, a distance measure dij giving the distance of two elements i (proto-
type i) and j (peptide j) is to be defined. In order to compare area-normalised
likelihood curves i and j the size of the overlapping area A is the distance measure
if there is a partial overlap of curves. Then the distance dij is given by
dij =
{
0 ≤ 1− A < 1 partial overlap of the curves i and j
0 total overlap of the curves i and j
(5.11)
with A = size of overlapping areas of the curves i and j.
Contrary, if the curves i, j are not overlapping, dij is defined by the distance
of the curves i and j with regard to the scaling of the x-axis which is given by
the distance of the highest calculated regulation factor xmax of the lower regulated
element el1 and the lowest calculated regulation factor xmin of the higher regulated
element el2. Since dij = 1 if the curves i and j do not overlap, this is the minimum
value for non-overlapping curves and must be added to the calculated distance.
Therefore, in the case of non-overlapping curves i and j the distance measure dij
is given by
di,j = x
(el2)
min − x(el1)max + 1 (5.12)
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Initially, a prototype curve representing all likelihood curves of the protein is
calculated. In contrast to the prototype generation given in section 5.3.2.1 the
distance measure dij now is based on the number of overlapping areas. Therefore,
the prototype curve must overlap with the majority of the peptide likelihood curves
and its likelihood has to be greater than zero at every discretised regulation factor.
In detail, the prototype is calculated by the detection of the number of overlapping
curves for every area that is located below the likelihood curves. Afterwards,
areas, which are part of the highest number of likelihood curves are added to the
prototype curve subsequently. This process is finished as soon as the total area of
the prototype curve reaches 1.
The second step consists of repeatedly calculating the distances dij of every
peptide likelihood curve and the prototype by application of (5.11) and (5.12)
and removing the most distant object until there are no likelihood curves left.
The respective distances of the removed curves are plotted against the number of
iterations within a plot.
Finally, this plot shows the number of different regulatory peptide clusters. In
the case of one cluster on the one hand the entries are arranged homogeneously
and close to each other. In the case of multiple clusters on the other hand, there
are groups of entries. After removing the last curve of a cluster a significant step
can be observed in the plot. It should be noted that the distance of two curves
within a cluster is always smaller than 1.
The following figures show the results obtained by the method of removing the
most distant curves. Figure 5.6 illustrates the peptide likelihood plots of the
proteins K2C6A and HSP71 as well as the associated plots visualising the results
obtained by the method of removing the most distant curves. The left plot is
associated with the upper protein (K2C6A) and shows a significant step indicating
two well separated clusters. The plot on the right hand side is associated with the
lower protein (HSP71) and shows no step indicating one single cluster. Both results
are more or less in accordance with the corresponding likelihood plots, K2C6A may
consist of two or three clusters. Figure 5.7, however, shows two proteins (NEK9
and MK01) whose numbers of clusters is wrongly determined by the presented
approach. The left plot is associated with the upper likelihood plot (NEK9) and
shows no significant decreasing step indicating one single cluster. The plot on
the right hand side is associated with the lower protein plot (MK01) and suggests
three clusters since the step between the first and the second point is very small.
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Figure 5.6: Peptide likelihood plots and corresponding function plots visualising the results
obtained by the method of removing the most distant curves. The left result plot is associated
with the upper protein (K2C6A) and shows a significant step indicating two well separated
clusters. The plot on the right hand side is associated with the lower protein (HSP71) and
shows no step indicating one single cluster.
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In summary, the method returns roughly correct outcomes in the examples given
in Figure 5.6, whereas it fails in the examples given in Figure 5.7. A strong
limitation of this approach becomes clear when a protein is lacking a significant
number of equally regulated peptides clustering into one cluster as shown in Figure
5.7.
Furthermore, the method is not able to distinguish between different clusters
having similar distances to the main cluster but are placed on opposite orienta-
tions. Since the test is using distances that neglect the orientation (lower or higher
regulated than the main cluster), two similar distant but adversely located clus-
ters result in a common step in the plot. Therefore, the test is not suitable for
determining the number of clusters, but only for the discrimination of one cluster
on the one hand and multiple clusters on the other hand. An example is given
in Figure 5.8: Next to the main cluster in the middle are additional clusters on
the left as well as on the right. Both marginal clusters are located very closely to
the main cluster but they are not overlapping. Regarding the corresponding result
plot, it can be clearly observed that four curves are removed in the beginning and
after a significant drop the remaining curves follow. The curves removed initially
originate from the marginal clusters (the left cluster consists of three curves which
can not be kept apart visually in the likelihood plot).
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Figure 5.7: Peptide likelihood plots and corresponding function plots visualising the results
obtained by the method of removing the most distant curves. The left result plot is associated
with the upper protein (NEK9) and shows no significant step indicating one cluster. The
plot on the right hand side is associated with the lower protein (MK01) and contrary to
expectations it shows no significant step as well. Both results are not in accordance with the
corresponding likelihood plots. NEK9 consists of three clusters, whereas MK01 consists of
two clusters.
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Figure 5.8: Peptide likelihood plot and corresponding function plot visualising the results
obtained by the method of removing the most distant curves. The likelihood plot shows 17
peptide curves, which cluster into three groups. The leftmost cluster is composed of three
curves, the cluster in the middle consists of 13 peptide curves and the rightmost cluster
contains one curve. Distances between the main cluster in the middle and both marginal
clusters are more or less equal. The corresponding result plot indicates that the protein is
composed of two peptide clusters.
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Maximisation of the Overlapping Areas
Although the former strategy is able to distinguish whether a protein consists of
one or more peptide clusters, the determination of the exact number of clusters is
not possible in all cases. Therefore, a new approach based on maximisation of the
overlapping areas below the peptide likelihood curves is developed. The general
idea is the step-by-step elimination of those curves, contributing fewest to the
overlapping area Ai, in which the majority of the curves participate (i = number
of contributing curves). Initially, the area An (n = total number of curves) that all
curves participate is determined. If there is no overlapping area below all curves,
the number of contributing curves is reduced. Non-overlapping curves are the first
ones to be removed sequentially. The size Si of the calculated area Ai is plotted
over the number of iteration within a result plot. Subsequently, the curve which
contributes least to the overlapping area is removed. However, after removing one
curve from the dataset, calculation of the area where most of the curves overlap is
repeated in order to remove the fewest contributing curve in the next step. Having
found the actual overlapping area Ai−1 related to the reduced dataset containing
i − 1 curves the new area size Si−1 is plotted. Since the total area below each
likelihood curve is normalised to 1 the size of the overlapping area S is the same
for all contributing curves with 0 < S ≤ 1.
The number of clusters within a protein is identified by the interpretation of
the corresponding result plot. Significant steps indicate that the last curve of a
distant cluster is removed and a closer cluster (or the main cluster) is touched.
Even though one problem of the previous strategy – lack of a significant number
of equally regulated peptides – is resolved, the second issue remains. The main
problem of this new approach is to unify further clusters besides the main cluster,
if all clusters are well separated. In this case, the result plot only shows one
significant step between the main cluster and a combination of the further clusters.
Therefore, the method of maximisation of overlapping areas is helpful concerning
the detection of proteins clustering into one single cluster. For the determination
of the optimal number of clusters, however, this strategy fails. Figure 5.9 gives
two examples. The upper peptide plot shows a protein consisting of four peptides
clustering into two clusters. As the clusters overlap, the presented approach is able
to detect both clusters, which can be identified by the step between the second
and the third point in the result plot on the left hand side. The lower likelihood
plot shows a protein consisting of 17 peptides clustering into three groups. The
leftmost as well as the rightmost cluster do not overlap with the main cluster in
the middle. In the result plot, the leftmost four points seem to belong to one
cluster which is not the case. In fact, these four points belong to both the right
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cluster consisting of one curve and to the left cluster consisting of three curves
(two of them can not be distinguished since they are identical). Regarding the
second example this strategy is also not able to determine the optimal number of
peptide clusters of the protein.
86 5 Detection of Post-translational Modifications
Figure 5.9: Peptide likelihood plots and corresponding result plots visualising the outcomes
obtained by the method of removing least overlapping curves. The upper likelihood plot shows
a protein consisting of four peptides clustering into two clusters. The presented approach is
able to detect both clusters, which can be identified by the step between the second and the
third point in the result plot on the left hand side. The lower likelihood plot shows a protein
consisting of 17 peptides that cluster into three groups. The leftmost as well as the rightmost
cluster do not overlap with the main cluster in the middle. In the result plot the leftmost
four points seem to belong to one cluster which is not the case. In fact, these four points
belong to the right cluster consisting of one curve and to the left cluster consisting of three
curves (two of them can not be distinguished since they are identical).
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Maximum Fitness
The basis of the former approaches are founded on similarity between overlapping
areas below the likelihood curves. Both strategies are able to decide whether
a protein consists of one or more peptide clusters, but due to different resons,
they are not able to determine the number of clusters exactly. Thus, a further
approach is presented which is based on maximising the product of the likelihoods
of all peptides within in the same cluster. This method allows the detection of
outlying curves by concerning likelihoods instead of areas below cuves. Thereby,
every peptide curve is compared separately with all other curves of the protein.
The optimal overall regulation factor is found by maximising the total likelihood
by calculation of Ln for every possible regulation factor by
Ln =
n∏
i=1
l
(i)
rf (5.13)
where rf is the regarded regulation factor, l(i)rf = likelihood of curve i at regulation
factor rf and n = number of peptide curves. Adding a constant value (e.g. 0.1)
on every likelihood avoids to obtain zero for the whole result whenever one of the
factors is zero. This is similar to so-called laplace correction as commonly used for
naive bayes classifications for instance.
Following, every peptide curve x is removed individually and according to (5.13)
the total likelihood of the remaining peptides Ln−x is calculated which is based
on the optimal overall regulation factor relating to the remaining peptides. The
optimal regulation factor rfx and the corresponding likelihood Lx = lx of the
removed curve are given by the x- and the y-coordinate of the maximum peak.
From these values a weighted sum Ln,x is produced by
Ln,x =
n− 1
n
Ln−x +
1
n
Lx. (5.14)
Subsequently, the coefficient fx is calculated for every removed curve x by
fx =
Ln,x
Ln
(5.15)
In conclusion, with increasing distance of the removed peptide curve x and the
remaining curves the coefficient fx is growing. If the removed curve is located
within the main cluster, fx is low. For the analysis of results generated this way,
coefficients are to be found, that are significantly higher than those derived from
the other peptides. Unfortunately, the limits of this approach are met, if the
number of equally regulated peptides is not significantly higher than the number
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of differentially regulated peptides. Then the basis for the outlier recognition is
missing. The following figures (Figure 5.10 and Figure 5.11) illustrate the results of
this approach based on maximising the likelihoods. Both figures show two peptide
likelihood plots and the corresponding results of the maximum fitness method
visualised by means of result plots depicting the coefficients fx after removing
curve x. The respective coefficient of the removed curve is plotted against the
number of the curve. The approach successively analyses the peptides of the
proteins CSK21 and CDC2 (Figure 5.10). The resulting plot on the left hand side
related to the upper protein clearly shows one significant outlier and the plot on
the right hand side related to the lower protein shows three outliers. Figure 5.11
gives two examples which illustrate cases in that the maximum fitness method fails.
Both proteins consist of several clusters and lack a main cluster which serves as
base containing a large part of the peptides curves. Hence, no significant outliers
can be found in the resulting plots related with the proteins KC1D (left hand side)
and CDC2 (right hand side).
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Figure 5.10: Likelihood plots and corresponding result plots visualising the outcome of
the maximum fitness method for the identification of outlying peptides within one protein.
The upper protein is associated with the left result plot, the lower protein is associated with
the right one. Both resulting plots are based on a high number of curves building the main
cluster, one (CSK21) and three (CDK2) significant outliers can be distinguished.
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Figure 5.11: Likelihood plots and corresponding result plots visualising the outcome of the
maximum fitness method for the identification of outlying peptides within one protein. The
upper protein is associated with the left result plot, the lower one is associated with the right
plot. Both resulting plots show no clear outliers due to the lack of a main cluster serving as
data basis.
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5.3.3 Expectation-Maximisation Clustering
In summary, none of the strategies presented in section 5.3.2.3 is able to determine
credibly the exact number of peptide clusters. Each of them fails because of at
least one of the reasons: (i) lacking a main cluster of similar regulated peptide
curves that serve as basis (ii) failure to dinstinguish clusters regulated with similar
regulations in different directions in comparison with the main cluster.
So far, peptide likelihood curves were regarded as abstract objects and standard
crisp or fuzzy clustering algorithms were applied after adaption to the underlying
data. Most of the approaches for the development of validity measures focused on
maximising the number of overlapping curves and the determination of distances
and similarities.
However, in the purpose of the noise model likelihoods are to be maximised.
Therefore, an expectation-maximisation (EM) clustering algorithm is designed for
finding clusters based on maximisation of the likelihoods. This approach belongs
to the type of partitioning clustering algorithms.
5.3.3.1 Introduction into Expectation-Maximisation Clustering
The EM clustering algorithm computes probabilities of cluster memberships based
on one or more probability distributions. The goal of the clustering algorithm then
is to maximise the overall probability or likelihood of the data, given the (final)
clusters (Dempster et al., 1977; Hill and Lewicki, 2006).
5.3.3.2 Expectation-Maximisation Clustering of Peptide Likelihood Curves
This perferctly probabilistic approach acts on assumptions concerning both the
number of regulated peptides and the noise model. The basic idea is to find j
optimal regulation factors rfj, 1 ≤ j ≤ n, that each represent one cluster and are
able to generate i related likelihood curves, 1 ≤ i ≤ k. Every curve is related with
that regulation factor which is the most likely resulting in the highest likelihood.
The total likelihood Lj for any cluster j is calculated by
Lj =
k∏
i=1
fi,rfj (5.16)
with k = number of curves related to cluster j and f
k,rf = likelihood (fitness) of
curve i at regulation factor rf.
The optimal regulation factor of each cluster j is found by calculation of the
maximum Lj for every possible regulation factor within the cluster. Two important
factors have a significant impact on the assignment of curves to one cluster: First
of all, the initial partition strongly depends on the initialisation of regulation
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factors representing the specific clusters. Initialisation is performed by randomly
choosing j optimal peptide regulation factors which are given by the peaks of
the likelihood curves. This process is repeated in proportion to the number of
peptide curves. A frequent problem of this method is that single outlying curves
for the initialisation step can be missing. For example, a protein consisting of 20
peptides, from which 18 peptides cluster into two clusters and two peptides are each
separated, will be rarely initialised with both separated curves. As a consequence,
they will be related to other clusters instead of forming single clusters. For avoiding
these cases, the first of the repeated initialisation steps is predetermined: Since
outlier rarely are located in the centre of the plot, the curves which are used for
initialisation are those, having the lowest and the highest most likely regulation
factors. Following the initialisation, the partition of the clusters is modified – which
is the second important factor. As long as an improvement of the final result is
achieved, one curve is removed from its cluster and is related to another one. For
this reassignment, one curve has to be found, whose likelihood contribution to a
different cluster, that the curve is not assigned to, is highest. After removing the
selected curve from its previous cluster and adding it to the second best cluster,
the optimal regulation factors for all clusters are recalculated by application of
(5.16) and following maximisation of Lj.
Once the optimal regulation factors rfj for all clusters j are found and the cluster
likelihoods are computed, the total likelihood Lc is calculated by
Lc = Pc(
c∑
j=1
k
n
k∏
i=1
li,rfj) (5.17)
with Pc = probability of a protein clustering into c clusters according to a-priori
distribution P , c = number of clusters, k = number of curves related to cluster
j, n = total number of peptide curves within the protein and li,rfj = likelihood of
curve i for regulation factor rfj.
Finally, the highest of the maximum total likelihoods Lc for every possible num-
ber of clusters c gives the optimal cluster number as well as the optimal cluster
partition. The a-priori distribution P gives an instrument for weighting the possi-
ble numbers of clusters whereby expert knowledge about the frequency of typical
cluster numbers can be introduced. Table 5.2 gives the a-priori distribution, that
is used for the calculation of the results in this work.
5.3.3.3 Results of Expectation Maximisation Clustering
All examples given in the following are performed by using an a-priori distribution
Pc in (5.17) allowing the introduction of expert knowledge. From experiments it
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is estimated that the number of clusters averages the following frequencies (Table
5.2):
Table 5.2: A-priori distribution of occurring number of clusters in common protein datasets
derived from experiments.
1 Cluster 2 Clusters 3 Clusters 4 Clusters 5 Clusters 6 Clusters ≥ 7 Clusters
0.25 0.45 0.15 0.08 0.04 0.02
∑n
k=7 qk = 0.01
Several results returned by the previously discussed methods are difficult to
evaluate, mainly due to the determination of cluster numbers (i.e. Figures 5.4,
5.5, 5.8, 5.9, 5.11). In contrast, expectation maximisation clustering determines
several cluster partitions according to the strategy presented in section 5.3.3 and
returns that one which achieved the highest total likelihood. Hereby, the quality
of the analysis strongly depends on initialisation and variation of the assignment
of peptide curves to clusters. The advantage of this EM clustering approach is
clearness of its result: The total likelihood (numerical data) has to mximised and
can be compared for all possible numbers and partitions of clusters.
If a precise result can be achieved by one of the previous presented approaches, it
is often similar to that, which is returned by expectation maximisation clustering.
The most problems concerning the determination of the number or the partition
of clusters were observed in those cases when a protein is identified only by a few
peptides or when its peptides belong to several clusters which are regulated differ-
ently. A clear result is found by all presented algorithms if a protein is identified
by several similar regulated peptides and one outlying peptide. In contrast, all
of the previous methods fail if the number of consistently regulated peptides is
low (e.g. 2) and the same number of further peptides (2) is differently regulated
as given in Figure 5.12. However, here the expectation maximisation cluster-
ing clearly results in three clusters: one cluster containing the likelihood curves of
the peptides HCDSINSDFGSESGGCGDSSPGPSASQGPR (green) and AGGGAAEQEELHYIPIR
(yellow), another cluster consisting of S∼STVTEAPIAVVTSR (purple) and a third
cluster containing SST∼VTEAPIAVVTSR (grey).
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Figure 5.12: Protein NEK9 identified by four peptides clustering into three clusters. Both
leftmost peptide likelihood curves are assigned to the same cluster (yellow, green). Single
peptide clusters are each detected containing one nearly unregulated curve (purple) and a
significantly upregulated curve (grey).
HSP71 (Figure 5.13) was identified by five unphosphorylated peptides. The EM
clustering algorithm identifies only one cluster.
Figure 5.13: Likelihood plot of the protein HSP71.
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Limitations of EM Clustering
Multiplication of the peptide likelihoods for the calculation of the cluster likelihood
in (5.16) causes that forming a low number of clusters is preferred by the algorithm.
The increase of the total likelihood (compare (5.17)) is significantly higher when
an additional curves is added to the cluster resulting in multiplying the former
cluster likelihood by the likelihood of the additional curve. This is true if the
additional likelihood is greater than 1. In comparison, forming a separate cluster
causes a minimal increase of the total likelihood.
Furthermore, due to the weighting of the determined clusters by k
n
with k =
number of curves within the cluster and n = number of total curves of the protein
the algorithm tends to assign low-quality likelihood curves to clusters containing a
little number of curves which sometimes hides the existence of clusters consisting
of only one single curve.
For avoiding these effects, it is very profitable to remove well separated single
peptide clusters before applying the EM clustering algorithm. An intuitive crite-
rion for the identification of those is the calculation of overlaps of curves. If one
curve does not overlap with other curves with more than 5% of its total area, it is
defined to be well separated and removed from the dataset containing the peptide
likelihoods. Examples are given in Figure 5.14 and Table 5.3.
NEK9 (Figure 5.14, Table 5.3) was identified by 17 peptides that are assigned
to seven clusters by the EM clustering algorithm. NEK9 is known to be phospho-
rylated at S332 and T333 (peptide SSTVTEAPIAVVTSR).
EM clustering itself identifies only four peptide clusters within the data of NEK9
in the case of application without removing well separated single peptide clusters.
In this result two of the upregulated phosphopeptides are assigned to other clusters
as well as the corresponding downregulated unmodified peptide. Application of
EM clustering after removing clear single peptide clusters yields a very good result
identifying the different regulation of the unmodified peptide corresponding to the
phosphopeptides.
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Figure 5.14: Likelihood plot of NEK9 clustering into at least five clusters.
Table 5.3: Partition of peptides of the protein NEK9 into seven clusters which were
calculated by the presented EM clustering algorithm.
Cluster Peptides (RF)
1 SSTVTEAPIAVVTSR (−2.02)
2 QLSFYK (−1.7), LGINLLGGPLGGK (−1.56)
3 LLTFGCNK (−1.47), TFDATNPLNLCVK (−1.43),
TLNIFLTK (−1.36), VLACGLNEFNK (−1.34),
GAFGEATLYR (−1.29), VASEAPLEHKPQVEASSPR (−1.28),
LGDYGLAK (−1.27), LQGLVLK (−1.22)
4 VASEAPLEHKPQVEASS∼PR (−1.08), AGGGAAEQEELHYIPIR (−1.07),
VTLLNAPTK (1.0)
5 S∼STVTEAPIAVVTSR (1.84)
6 SST∼VTEAPIAVVTSR (4.02)
7 SSTVT∼EAPIAVVTSR (7.90)
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MK01 (Figure 5.15, Table 5.4) was identified by three upregulated phospho-
peptides (identical sequences, different phosphosites), six slightly downregulated
unmodified peptides and the unmodified peptide corresponding to the phospho-
peptides which is significantly downregulated. Eight clusters are determined by
EM clustering. Indeed, two phosphopeptides (RF 4.50 and 4.69) obviously form-
ing one cluster (similar regulations and shapes) are assigned to separate clusters.
This is resulting from maximum likelihoods < 1 leading to a low result during
mulitplication. On the other hand, addition of separate clusters gains the sum of
the maximum likelihoods.
Figure 5.15: Likelihood plot of MK01 forming at least four clusters.
Table 5.4: Partition of peptides of the protein MK01 into eight clusters which were
calculated by the presented EM clustering algorithm.
Cluster Peptides (RF)
1 VADPDHDHTGFLTEYVATR (−5.93)
2 GQVFDVGPR (−1.40)
3 ISPFEHQTYCQR (−1.20), NYLLSLPHK (−1.15), ALDLLDK (−1.08)
4 HENIIGINDIIR (1.13)
5 LFPNADSK (1.20)
6 VADPDHDHTGFLT∼EYVATR (4.50)
7 VADPDHDHTGFLTEY∼VATR (4.69)
8 VADPDHDHTGFLT∼EY∼VATR (18.91)
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Results
In the following examples the EM clustering approach is applied to the proteins
shown in the previous examples. Most of them could not be processed correctly by
the former clustering approaches whereas EM clustering returns clear and plausible
results. Figures 5.16 - 5.22 dipict the likelihood plots, Tables 5.5 - 5.11 list all
identified peptides, the calculated regulation factors determined by (4.2) and the
assignment of the peptides to clusters calculated by EM clustering.
All peptides forming own clusters are checked by a database query
(Uniprot/Swissprot3) whether they can be the target of proteolysis (if they are
located in the beginning or in the end of the protein), or are known to be modi-
fied. All examples are taken from the dataset F074086.dat (HGF experiment, T.
Reinl).
3http://www.expasy.org/uniprot/
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I. ECH1 (Figure 5.16, Table 5.5) was identified by 14 unphosphorylated pep-
tides that were assigned to three clusters by EM clustering. The peptide
VFPDK forming an own cluster is not known to be modified. Degradation
can be excluded due to the localisation of this peptide (positions 60-65 from
328 amino acids in total) within the protein. Therefore, this peptide has
to be analysed regarding isoforms and wrong assignment in order to decide
whether a novel modification can be assumed and further investigations are
started.
Figure 5.16: Likelihood plot of the protein ECH1 (no modifications detected).
Table 5.5: Partition of peptides of the protein ECH1 into three clusters which were
calculated by the presented expectation-maximisation clustering algorithm.
Cluster Peptides (RF)
1 (K)MMADEALGSGLVSR (−1.57), VTSAQK (−1.49)
2 EVDVGLAADVGTLQR (−1.22), SPVAVQST(KVNLLYSR) (−1.22),
SVQATTENK (−1.21), AVVISGAGK (−1.19),
VIGNQSLVNELAFTAR (−1.18), YQETFNVIER (−1.18),
TVTFSK(L) (−1.16), YCAQDAFFQVK (−1.16),
LTGSSAQEEASGVALGEAPDHSYESLR (−1.14), EMVECFNK (−1.12),
VNLLYSR (−1.12)
3 VFPDK (1.32)
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II. KC1D (Figure 5.17, Table 5.6) was identified by eight peptides which cluster
into three clusters. Among these are two known phosphopeptides which are
phosphorylated at five different amino acids. The peptide IEYIHSK forming
an own cluster is not known to be modified. Degradation is excluded due to
the localisation (positions 116-121 from 415 amino acids in total) of the pep-
tide within the protein. This peptide has to be analysed regarding isoforms
and wrong assignment in order to decide whether a novel modification can
be assumed and further investigations are started.
Figure 5.17: Likelihood plot of the protein KC1D, 4 phosphopeptides are detected.
Table 5.6: Partition of peptides of the protein KC1D into three clusters which were
calculated by the presented expectation-maximisation clustering algorithm.
Cluster Peptides (RF)
1 GAPVNIS∼SSDLTGR (−1.77), GAPVNISSSDLTGR (−1.48)
2 TVLLLADQMISR (−1.26), GAPVNISS∼SDLTGR (−1.17),
GLPS∼TAS∼GR (−1.08), GLPSTAS∼GR (−1.01), GLPS∼T∼ASGR (1.01),
3 IEYIHSK (1.25)
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III. K2C6A (Figure 5.18, Table 5.7) was identified by six unphosphorylated pep-
tides which are assigned to four clusters. The peptide FASFIDK forming an
own cluster is not known to be modified. Degradation is excluded due to the
localisation (positions 174-180 from 564 amino acids in total) of the peptide
in the middle of the protein. Therefore, this peptide has to be analysed re-
garding isoforms and wrong assignment in order to decide whether a novel
modification can be assumed and further investigations are started.
Figure 5.18: Likelihood plot of the protein K2C6A.
Table 5.7: Partition of peptides of the protein K2C6A into three clusters which were
calculated by the presented expectation-maximisation clustering algorithm.
1 ADTLTDEINFLR (−4.56), QEIAEINR (−4.31), TAAENEFVTLK (−4.27)
2 FASFIDK (1.34)
3 FLEQQNK (1.58), EYQELMNVK (1.61)
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IV. CDC2 (Figure 5.19, Table 5.8) was identified by 15 peptides. Among these is
one known phosphopeptide which is phosphorylated at two different amino
acids. EM clustering with removing the single peptide cluster TTGQVVAMK
determines six clusters conforming the visual presentation. The database
query returns no known modifications regarding the upregulated peptide
TTGQVVAMK. However, since it is located in the beginning of the protein (po-
sitions 25-34 from 297 amino acids in total) degradation can not be excluded
for causing the different regulation.
Figure 5.19: Likelihood plot of the protein CDC2 (3 phosphopeptides detected).
Table 5.8: Partition of peptides of the protein CDC2 into six clusters which were
calculated by the presented expectation-maximisation clustering algorithm.
Cluster Peptides (RF)
1 SPEVLLGSAR (−2.19)
2 IGEGT∼YGVVYK (−1.05), IGEGT∼Y∼GVVYK (1.02)
3 IGEGTY∼GVVYK (1.08)
4 (IR)LESEEEGVPSTAIR (1.18), NLDENGLDLLSK (1.19), EISLLK (1.22)
5 DLKPQNLLIDDK (1.35)
6 MALNHPYFNDLDNQIK (1.39), YLDSIPPGQYMDSSLVK (1.48),
ALGTPNNEVWPEVESLQDYK (1.49), MLIYDPAK (1.52),
IGEGTYGVVYK (1.53)
7 TTGQVVAMK (2.20)
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V. The protein ACLY (Figure 5.20, Table 5.9) was identified by four slightly
downregulated peptides and one slightly upregulated peptide, which cluster
into two clusters. None of these peptides is known to be modified. The
peptide LLVGVDEK is detected as single cluster peptide. A database query
returns no known modifications concerning this peptide. Since it is located
in the middle of the protein (positions 152-159 from 1101 amino acids in
total) proteolysis can be excluded. Analyses regarding isoforms and wrong
assignment are necessary in order to decide whether a novel modification can
be assumed and further investigations are started.
Figure 5.20: Likelihood plot of the protein ACLY.
Table 5.9: Partition of peptides of the protein ACLY into two clusters which were
calculated by the presented expectation-maximisation clustering algorithm.
Cluster Peptides (RF)
1 LTLLNPK (−1.26), ADEVAPAK (−1.14),
FGGALDAAAK (−1.13), TIAIIAEGIPEALTR (−1.12)
2 LLVGVDEK (1.26)
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VI. CCNA2 (Figure 5.21, Table 5.10) was identified by eight peptides (Figure
5.21, Table 5.10) which are assigned to three clusters. Most of the pep-
tides are not regulated or slightly downregulated. The peptides AALAVLK
and YHGVSLLNPPETLNL are identified to form own clusters. A database query
returns no known modifications concerning these peptides. The amino acids
of the peptide YHGVSLLNPPETLNL are the last ones of the protein (positions
420-432 from 432 amino acids in total). Therefore, besides a potential un-
known modification protein degradation can not be excluded. Due to the
location of AALAVLK is located in the middle of the protein (positions 152-
159 from 432 amino acids in total) and hence, proteolysis can be excluded.
Analyses of the latter peptide regarding isoforms and wrong assignment are
necessary in order to decide whether a novel modification can be assumed
and further investigations are started.
Figure 5.21: Likelihood plot of the protein CCNA2.
Table 5.10: Partition of peptides of the protein CCNA2 into two clusters which were
calculated by the presented expectation-maximisation clustering algorithm.
Cluster Peptides (RF)
1 YHGVSLLNPPETLNL (−1.61)
2 VAPLK (−1.14), APQHAQQSIR (−1.10), EDALAFNSAISLPGPR (−1.08),
DLPVNDEHVTVPPWK (−1.07), QPAFTIHVDEAEK(EAQK) (1.05)
3 AALAVLK (1.34)
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VII. The protein K0528 (Figure 5.22, Table 5.11) was identified by seven un-
modified peptides and one known phosphpeptide (green, RF = 1.05). Ac-
cording to EM clustering the peptides SQSESSDEVTELDLSHGK (light purple,
RF = −6.21) and IHNPDEPETR (dark purple, RF = −2.41) each form separate
clusters. Both are not known to be modified. Due to the location of both
peptides (positions 379-388 and 657-674 from 1000 amino acids in total) pro-
teolysis can be excluded. Analyses of the both regarding isoforms and wrong
assignment are necessary in order to decide whether novel modifications can
be assumed and further investigations are started.
Figure 5.22: Likelihood plot of the protein K0528.
Table 5.11: Partition of peptides of the protein K0528 into four clusters which were
calculated by the presented expectation-maximisation clustering algorithm.
Cluster Peptides (RF)
1 SQSESSDEVTELDLSHGK (−6.21)
2 IHNPDEPETR (−2.41)
3 AIGTACTLDK (−1.37), LEENLPTR (−1.35), EGGPFK (−1.31), TPVEK (1.29), SLYFK (−1.19)
4 LSSPAAFLPACNS∼PSK (1.05)
6 Conclusions and Outlook
The completely novel concept of presenting regulatory information by likelihood
curves provides an intuitive and comfortable approach to illustrate both the re-
sulting regulation factor and the underlying data quality. In comparison with
long tables containing hundreds and thousands of peptides, their ion intensities
and regulation factors, a feasible system was created for analyses of quantita-
tive experiments. The established software tool iTRAQassist combines all com-
ponents necessary for user-defined analyses comprising data preprocessing, statis-
tically confirmed calculation of regulatory information as well as visualisation of
peptide expression profiles, emphasising differently regulated peptides.
The exact calculation of the most probable regulation factor and even more the
evaluation of alternative regulation factors is only possible due to the definition
of an MS instrument type specific noise model. Although this model was vali-
dated carefully, alternative noise models corresponding to alternative workflows
might further improve this strategy. If necessary, this workflow allows to substi-
tute the model selected in this work without interfering the following calculations.
Essentially, the model used should allow computation of the standard deviation
depending on the measured intensity. Adaptability to different workflows also
includes customisation to different kinds of (high-throughput) data.
The availability of multiple peptide likelihood curves exhibiting different shapes
and different regulations within one protein plot provides a basis for clustering al-
gorithms that are able to detect differentially regulated peptides within one protein
in an automatic manner. Investigations of novel post-translational modifications
(PTM) are highly topical in biological research and can be supported by cluster-
ing analyses in order to detect differentially regulated peptides. A novel clustering
algorithm was developed in this work considering properties and characteristics of
likelihood curves. Application of this algorithm to experimental data containing
regulated phosphopeptides achieved good results regarding the identification of
regulated phosphopeptides. Furthermore, several unmodified regulated peptides
could be found as well, to identify the causes for the regulations is an open task.
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Future work In the meantime, highly productive devices as well as 8 plex
iTRAQTM labelling reagents are available. This provides alternative strategies
for the estimation of the model parameters. It should be investigated, whether
labelling and combining eight identical treated subsamples could generate enough
information to estimate the parameters from a complex sample. Due to powerful
devices the number of identified peptides covering a broad intensity range could
be increased.
Possibly, the results of the clustering algorithm could be further improved by
exclusion of peptides exhibiting extremely low iTRAQTM reporter intensities. By
avoiding the assignment of a single peptide cluster and a very broad curve (result-
ing from low iTRAQTM reporter intensities) identification of single peptide clusters
could be improved.
Detecting unknown post-translational modifications of peptides not only includes
the identification of differentially regulated peptides but requires in-depth investi-
gations of the obtained clustering results. Besides post-translational modifications,
several other reasons can cause regulations of peptides, e.g. wrong peptide to pro-
tein assignments or the existence of isoforms. By database queries and comparisons
with literature as much as possible information must be gathered in order to ex-
clude regulations that are not caused by post-translational modifications or to find
further references to PTM interlinking new experimental data with established in-
formation. After excluding regulations that can be explained by other reasons
than post-translational modifications, additional analyses have to be performed
in order to identify the modification type out of more than 200 possible kinds of
peptide modifications.
All such regulations happen in time and space. It is therefore of further interest
to analyse phosphorylation events in regards to the time of modification and the
cell component they took place in. The aim is to explore in-depth the order
and rate of the signalling networks that pass on information by activation and
deactivation of proteins through PTM. Because of the immense amount of data
such a research requires, new automated ways to construct pathways from existing
information have to be developed. Again, this can rely on information provided
by the proposed clustering algorithm to predict the likeliness of interconnections
which can then be validated.
Efforts have been made to continue the results of this work. A new thesis is in
preparation which will build onto the clustering results to predict aforementioned
network interactions from high-throughput experiments.
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